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ABSTRACT
RATIONALE: Carbohydrate (CHO) ingestion is a recommended strategy to reduce the risk 
o f hypoglycaemia during and after exercise in people with type 1 diabetes (T1DM). 
Emerging research has shown that pre-exercise consumption of the low glycaemic index (GI) 
CHO isomaltulose increases blood glucose (BG) concentrations less and still protects against 
hypoglycaemia. However, glycaemic and performance benefits have been under-researched 
in T1DM following ingestion o f CHO with differing GIs. This study compared the metabolic 
and performance responses to running following ingestion of a low- and high- GI CHO in 
T1DM.
METHODS: With ethical approval, seven individuals (34±5 years, 70±2 kg, HbAic: 
76.6±6.5 m m olm of1) attended the laboratory twice following preliminary testing. 
Participants were provided with either 0.6 g kg"1 BM of either dextrose (DEX) or isomaltulose 
(ISO) immediately after a 50% reduced rapid-acting insulin dose. After 2-h rest participants 
completed a discontinuous incremental treadmill protocol (4-min running: 90 s rest at 31±1,
41±2, 53±2, 69±3 and 80±2% VO2 peak) before a 10 min performance run. Blood samples 
were obtained throughout and analysed immediately for BG, lactate and other variables. Data 
are expressed as mean±SEM and analysed using repeated measures ANOVA with statistical 
significance (P<0.05).
RESULTS: BG peak during the 2-h rest was lower after ingestion of ISO (ISO +5.6±0.4 vs. 
DEX +10.3±0.7 mmol L '1, P<0.05). BG reductions throughout the submaximal exercise were 
similar (ISO -1.9±0.5 vs. DEX -1.0±0.5 mmol L"1, P>0.05) as were changes following the 
performance bout (ISO +0.7±0.4 vs. DEX +0.7±0.3 mmol L"1, P>0.05). Lactate was higher in 
the 2-h rest period in ISO (P<0.05), although there were no differences once exercise began. 
Distance covered during the performance bout was comparable (ISO 1.14±0.09 vs. DEX 
1.15±0.09 km, P>0.05).
CONCLUSION: Pre-exercise consumption of ISO is an effective CHO for those exercising 
T1DM individuals wishing to improve glycaemic control without loss of exercise 
performance.
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Figure 1.1 Glucoregulatory processes in non-diabetic and T1DM individuals (A) illustrates the 
hormonal secretions and associated glycaemic responses, (B) illustrates the difficulties o f  
glucoregulation in T1DM and the dangers o f too much or too little insulin administration, compiled 
using data from Cryer, Davis & Shamoon (2003); Khan & Pessin (2002).
Latest figures (Diabetes UK, 2009) report that between 140,000 -  420,000 individuals are 
currently diagnosed with type 1 diabetes mellitus (T1DM) in the UK. T1DM is a condition 
that is autoimmune in nature that selectively targets and destroys the insulin producing P-cells 
of the Islets of Langerhans located in the pancreas (Devendra, Liu & Eisenbarth, 2004). 
Insulin, alongside glucagon and catecholamines (especially adrenaline), are key regulators in 
levels of blood glucose (Figure 1.1 A) and without these hormones and associated responses
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individuals with T1DM are prone to episodes of either hypo- or hyperglycaemia (Figure 
1.1B). The principal treatment in T1DM is the exogenous administration of insulin. Insulin is 
injected subcutaneously usually by a series of injections, these regimens range from two 
(conventional) to four (multi daily or basal bolus) administrations o f insulin per day 
(Stephens & Riddle, 2003). The exogenous administration of insulin can sometimes be 
difficult to regulate which may lead to an individual experiencing either hypo- (if too much 
insulin is administered) or hyperglycaemia (if too little insulin is administered) (Figure 1.1B). 
However, developments in technology now offer individuals the option to be intensely 
treated with a battery operated insulin pump that regularly administers doses of insulin 
(Stephens & Riddle, 2003).
Diet and exercise alongside insulin administration are important components in the treatment 
o f T1DM (Diabetes UK, 2011). Individuals with T1DM are actively encouraged to exercise 
as much as their healthy counterparts on the basis that they are in good glycaemic control and 
have no cardiovascular complications (Zinman, Ruderman, Campaigne, Devlin & Schneider, 
2004). Regular participation in physical activity and/or exercise has been shown to have a 
number of benefits for individuals with T1DM; increased levels of cardiorespiratory fitness 
have been widely reported (Lehmann, Kaplan, Bingisser, Bloch & Spinas, 1997; Laaksonen 
et al., 2000; D ’hooge et al., 2011) as have cardiovascular health and specific benefits to 
individuals with T1DM. Insulin sensitivity has been shown to be improved by 23 ± 5% after 
completion of a 12 week aerobic exercise intervention (Landt, Campaigne, James & Sperling, 
1985), whist glycaemic control has also documented to be improved (Mosher, Nash, Perry, 
LaPerriere & Goldberg, 1998; Stratton, Wilson, Endres & Goldstein 1987). In addition to 
cardiovascular and metabolic benefits, regular engagement of exercise in persons with long 
standing T1DM has been proven to increase feelings of health related quality of life 
(Wiesinger et al., 2001). However, even with all the evident benefits ~ 60% of the adult 
T1DM population report sedentary behaviour (Thomas, Alder & Leese, 2004; Plotnikoff et 
al., 2006). The greatest barrier to exercise in T1DM is the fear o f experiencing 
hypoglycaemia (Brazeau, Rabasa-Lhoret, Strychar & Mircescu, 2008). Hypoglycaemia is the 
result of too much insulin, not enough food or a combination of these two factors.
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Current guidelines to reduce the incidence of hypoglycaemia during exercise recommend the 
reduction of pre-exercise insulin doses and/or the consumption of carbohydrate (CHO) prior 
to exercise (Riddell & Perkins, 2006; Lumb & Gallen, 2009; Perry & Gallen, 2009). The 
need to reduce pre-exercise insulin doses was first documented by Lawrence (1926) to lower 
the risk of hyperinsulinemia in the exercising individual. As insulin is exogenously 
administered in T1DM, circulating levels of the hormone do not decrease at the onset of 
exercise as they would in non-diabetic individuals. No decrease in circulating insulin 
combined with an insufficient glucagon response results in an unchanged insulin to glucagon 
ratio, which in turn increases the risk that hepatic glucose production will not increase to 
match the increased fuel requirement of exercise (Lumb & Gallen, 2009). Higher than normal 
insulin levels can also result in the translocation of GLUT-4 transporters resulting in glucose 
uptake in the muscle and adipose tissues (Khan & Pessin, 2002). To counteract these declines 
in blood glucose, carbohydrate consumption is recommended prior to and/or during exercise 
(De Feo et al., 2006; Lumb & Gallen, 2009). However, there is a lack of research pertaining 
to the type o f CHO to be ingested in these individuals as it is an important consideration that 
not all CHO are the same and can be classified by their glycaemic index (GI).
The GI was a concept first introduced in 1981 by Jenkins and colleagues categorised on 
postprandial blood glucose responses after ingestion of foodstuff in direct comparison to the 
responses after ingestion of an identical amount o f a reference food usually either white bread 
or glucose. The GI o f foodstuff is an important consideration in T1DM individuals. 
Incorporating low GI foods into daily diets of T1DM individuals as opposed to higher GI 
foodstuff has shown to reduce peak blood glucose and daytime mean blood glucose values 
with no difference in nadir or nocturnal blood glucose levels. These lesser excursions can 
benefit glycaemic control and enhance quality of life in T1DM (Gilbertson et al., 2001; 
Nansel, Gellar & McGill, 2008). Moreover, selecting low GI foodstuff as an alternative to 
conventional meals has a small but clinical benefit similar to that o f pharmacological 
therapies that combat postprandial hyperglycaemia (Brand-Miller, Hayne, Petocz & 
Colagiuri, 2003). Low GI diets can also increase feelings of satiety, decreasing hunger ratings 
after meals (Stephenson, Williams & Nute, 2005) and reduce energy intake at lunch when 
low GI foodstuff are ingested for breakfast (Warren, Henry & Simonite, 2003) which can be 
potentially beneficial for weight loss/control (Ball et al., 2003).
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Recent literature (West et al., 2011b) has shown that pre-exercise ingestion o f the low GI 
CHO isomaltulose (Palatinose®) can protect against hypoglycaemia equally well as a high GI 
CHO following 45 minutes of continuous moderate intensity exercise in T1DM. Lesser 
reliance on carbohydrate oxidation and higher combustion rates of lipids during exercise after 
isomaltulose consumption were attributed to this finding. Ingestion of isomaltulose also 
results in lesser excursions in levels of blood glucose prior to exercise than a high GI CHO 
which is an important consideration in regards to glycaemic control in this clinical 
population.
There is currently no research directly examining exercise performance in T1DM after 
manipulation of pre-exercise CHO and the associated glycaemic responses before, during and 
post-exercise. Performance testing involves high intensity exercise which increases the 
possibility of hyperglycaemia during and after exercise in T1DM even in those individuals 
that have good glycaemic control (Mitchell, Abraham, Schiffen, Leiter & Marliss, 1988). 
Regular hyperglycaemic episodes can have both acute and long term complications, which 
include increased risk of cardiovascular disease, hypertension, sudden death and reduced 
exercise capacity (Peirce, 1999). Whilst it is established that low GI CHO supplementation 
can equally reduce incidence o f hypoglycaemia as high GI CHO supplementation (West et 
al., 201 lb) the lower blood glucose excursions witnessed warrants further investigation. This 
study will therefore examine the blood glucose responses following ingestion of high and low 
GI CHO supplementation and whether the lower excursions previously reported (West et al, 
2011b) limit the incidences of negative hyperglycaemia in T1DM at high intensity running. 
Exercise performance will also be evaluated to investigate whether the better glycaemia and 
more reliance on lipid oxidation witnessed in previous literature after isomaltulose ingestion 
(West et al., 201 lb) may impact upon subsequent performance testing.
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2.0 REVIEW OF LITERATURE
2.1 Type 1 Diabetes Mellitus Overview
Latest figures (Diabetes UK, 2009) report that 2.8 million people have been diagnosed with 
diabetes in the UK, with type 1 diabetes mellitus (T1DM) accounting for 5 -  15% of these 
cases.
T1DM is a condition, autoimmune in nature, which selectively targets and destroys the p- 
cells of the Islets of Langerhans in the pancreas and inhibits the production of insulin, 
(Devendra, Liu & Eisenbarth, 2004) an important hormone responsible for regulating levels 
of blood glucose. Glucagon and catecholamines are also both key principle glucoregulators 
(Figure 2.1) and secretions of these hormones can also become blunted in T1DM (Cryer, 
Davis & Shamoon, 2003). Therefore, individuals with T1DM are prone to either elevated 
(hyperglycaemia) or low (hypoglycaemia) levels of blood glucose (Figure 1.1B). Suffering 
from an episode of either hypo- or hyperglycaemia can be at the very least an unpleasant 
experience for the individual concerned (Cryer et al., 2003; Warren, Deary & Frier, 2003).
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Figure 2.1 The process of glucoregulation and influences o f counter-regulatory hormones in healthy 
individuals, compiled using data from Cryer et al. (2003); Khan & Pessin (2002).
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Individuals with T1DM are predisposed to a number of risk factors for a range o f illnesses 
and life expectancy is said to be on average 11.6 -  19.0 years shorter than their healthy 
counterparts dependent on age o f diagnosis (Venkat Narayan, Boyle, Thompson, Sorensen & 
Williamson, 2003). In addition, there is a reported 10-fold increased chance of developing 
cardiovascular disease in T1DM with risk factors including diabetic or autonomic 
neuropathy, hypertension, dyslipidaemia and more specific microvascular cardiac disease 
(Daneman, 2006).
To counteract the body’s inability to naturally produce insulin, individuals with T1DM are 
treated with exogenously administered insulin. Insulin is typically injected subcutaneously 2 
-  4 times per day dependent on treatment regimen. Conventional treatment involves two 
injections per day usually at breakfast and dinner o f a combination of short and an 
intermediate acting dosage. Individuals can also choose to adopt a more intensive approach 
and inject themselves four times per day. This method of treatment involves one injection of 
long acting analogue prior to sleep or first thing in the morning and three further 
administrations at mealtimes of rapid acting insulin. This treatment is referred to as multiple 
daily injections or basal-bolus regimen (Stephens & Riddle, 2003). Recent developments now 
allow for an additional option in intensive treatment which involves the use of an insulin 
pump. Insulin pumps are battery operated and provide rapid-acting insulin, usually insulin 
aspart at frequent intervals through a catheter administered subcutaneously in the abdomen 
with the bolus of insulin adjusted during meals to more precisely replicate the natural pattern 
of insulin secretion (Stephens & Riddle, 2003).
In addition to insulin therapy, a healthy lifestyle is also a key component in diabetes 
treatment, incorporating a balanced diet and regular exercise are strongly encouraged in 
people with T1DM (Diabetes UK, 2011).
2.2 Benefits of exercise for individuals with T1DM
The latest position statement encourages individuals with T1DM to partake in physical 
activity and exercise at any level on the basis that they have good glycaemic control and no 
other cardiovascular or diabetic complications apart from mild background nonproliferative 
retinopathy (Zinman, Ruderman, Campaigne, Devlin & Schneider, 2004). Regular
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participation in physical activity and/or exercise has been shown to have a number o f benefits 
for individuals with T1DM; increased levels of cardiorespiratory fitness have been widely 
reported (Lehmann, Kaplan, Bingisser, Bloch & Spinas, 1997; Laaksonen et al., 2000; 
D’hooge et ah, 2011) as have cardiovascular health and specific benefits to individuals with 
T1DM. However, functional aerobic capacity in T1DM is reportedly lower than non-diabetic 
controls as characterised in levels of maximal oxygen consumption (Komatsu et al., 2005) 
and in time to exhaustion assessments (Komatsu et al., 2005; Ramires et al., 1997).
Insulin sensitivity has been shown to be improved by 23 ± 5% after completion o f a 12-week 
aerobic exercise intervention when compared to a control group (Landt, Campaigne, James & 
Sperling, 1985). Improvement in glycaemic control following exercise interventions has also 
been documented. Stratton, Wilson, Endres & Goldstein (1987) reported better glycaemic 
control after an 8-week supervised training program as reflected in glycosylated serum 
albumin and blood glucose values. Completion of a 12-week circuit training intervention 
comprising both aerobic and resistance activities benefits glycaemic control further, with 
reported reductions of .96% point in HbAic scores (Mosher, Nash, Perry, LaPerriere & 
Goldberg, 1998). Mosher et al. also found that levels o f low density lipoprotein (LDL) 
cholesterol had fallen as a result o f the exercise intervention. Similar reductions in LDL 
cholesterol levels were also demonstrated after a 12 -  16 week moderate intensity exercise 
intervention (Laaksonen et al., 2000). Fuchsjager -  Mayrl et al. (2002) further demonstrated 
that participation in a four month training program of stationary cycling at 60 -  70% 
maximum heart rate improved vascular endothelial function in T1DM individuals, especially 
in flow-mediated dilation o f the brachial artery with an increase from 6.5 ± 1.1 to 9.8 ± 1.1% 
reported. This finding may be of some importance as recent literature (Gimenez et al., 2011) 
concluded that repeated episodes of hypoglycaemia aggravated preclinical atherosclerosis, 
more specifically in observing lower percentages of maximal flow-mediated brachial dilation 
and higher carotid and femoral intima-media thickness.
Apart from evident cardiovascular and metabolic benefits, regular engagement of exercise in 
persons with long standing T1DM has been proven to increase feelings of health related 
quality of life, particularly in social functioning and vitality scores (Wiesinger et al., 2001).
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2.3 Barriers to exercise for individuals with T1DM
Although benefits of regular physical activity and exercise are well documented and 
described previously (Chapter 2.2), for one reason or another not every individual with 
T1DM partakes in some type of exercise regularly with -60%  of T1DM adults reporting 
sedentary behaviour (Thomas, Alder & Leese, 2004; Plotnikoff et al., 2006).
Barriers to exercise were reported to be work schedule, low fitness level, loss of control over 
diabetes, with the strongest barrier to exercise being the fear of hypoglycaemia (Brazeau, 
Rabasa-Lhoret, Strychar & Mircescu, 2008). Brazeau et al. further commented that factors 
which influenced such responses were based around lack of basic knowledge in regards to 
insulin pharmacokinetics and strategies to implement prior to exercise to prevent 
hypoglycaemia. The same authors also discovered that those individuals that reported greater 
perceived barriers to exercise had poorer levels of glycaemic control as measured by HbAjc.
2.4 Hypoglycaemia and Hyperglycaemia
2.4.1 Definition, symptoms and causes of hypoglycaemia
Although quality of life in T1DM individuals has been enhanced through increased flexibility 
of timing in regards to exercise and meals with basal-bolus insulin treatments, the occurrence 
o f hypoglycaemia is still a frequent experience (Shalitin & Phillip, 2008). Hypoglycaemia is 
defined as a blood glucose concentration below 3.5 m m olL '1 and categorised further as 
severe hypoglycaemia if the individual requires assistance from another person (Rabasa- 
Lhoret, Bourque, Ducros & Chiasson, 2001).
Symptoms of hypoglycaemia can be classified as either autonomic, neuroglycopenic or 
general malaise. Autonomic symptoms are regulated by the autonomic nervous system, 
whilst neuroglycopenic symptoms result directly from low blood glucose concentrations on 
the brain (McAuley, Deary & Frier, 2001). Common autonomic responses to hypoglycaemia 
include sweating, palpitations, shaking and hunger, frequently experienced neuroglycopenic 
symptoms were confusion, drowsiness, odd behaviour, speech difficulty and incoordination, 
with headaches and nausea reported as general malaise symptoms (Deary, Hepburn, 
MacLeod & Frier, 1993).
Hypoglycaemia can be caused by exogenous insulin excess which results in levels of plasma 
glucose declining to low levels in T1DM. The fall in plasma glucose is not accompanied by a 
decrease in levels of insulin, simply as these levels are unregulated and the result o f passive 
absorption of administered insulin and the individual pharmacokinetics of the treatment. Due 
to this factor the first defence against hypoglycaemia is lost in established T1DM (Cryer et 
al., 2003). Decreasing levels o f plasma glucose is usually associated with increased glucagon 
secretion, which promotes hepatic glycogenolysis and gluconeogenesis and in turn raises 
plasma glucose concentrations (Cryer et al., 2003). In established T1DM this response is not 
present (Gerich, Langlois, Noacco, Karam & Forsham, 1973; Bolli et al., 1983), the absent 
response to glucose levels appears to be a signalling defect as glucagon secretory responses 
are present in relation to other stimuli (Cryer et al., 2003). It is currently unknown as to the 
mechanism to which inhibits the glucagon secretion, however there is a suggestion the absent 
response is related to endogenous insulin deficiency (Banarer, McGregor & Cryer, 2002).
Directly beneath glucagon in the hierarchy of counter-regulatory hormones in the defence 
against hypoglycaemia are catecholamines, more specifically the secretion and response of 
adrenaline. Catecholamines raise blood glucose concentrations through the combination of 
decreased glucose utilisation and increased rate of hepatic glucose production (Sherwin et al., 
1980). In T1DM this secretion has also been reported to be attenuated (Bolli et al., 1983; 
Amiel, Sherwin, Simonson & Tamborlane, 1988; Dagogo-Jack, Craft & Cryer, 1993), with 
secretions reported at lower plasma glucose concentrations in those individuals with strict 
glycaemic control (Amiel et al., 1988) and impaired further following previous episodes of 
hypoglycaemia (Dagogo-Jack et al., 1993). Apart from the blunted counter-regulatory 
response observed in T1DM (Cryer, 2002) one of the major contributors to hypoglycaemia is 
missed meals (Davis, Keating, Byrne, Russell & Jones, 1997; Boyle & Zrebiec, 2007), 
leading to decreased exogenous glucose delivery and therefore excess circulating insulin 
(Cryer et al., 2003).
Evening alcohol consumption can also impair morning glucose levels with hypoglycaemia a 
more frequent occurrence after individuals drank wine compared to water. Evening and 
overnight glycaemia was comparable with a decreased nocturnal secretion of growth 
hormone offering an explanation to the observed morning episodes of hypoglycaemia 
(Turner, Jenkins, Kerr, Sherwin & Cavan, 2001). Unfortunately, glycaemic control does not 
aid in preventing low blood glucose concentrations with a higher proportion of individuals
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with strict glycaemic control more likely to experience an episode of severe hypoglycaemia 
(Tavema et al., 2000).
Simplistically, hypoglycaemia may be caused by too much insulin and associated impaired 
counter-regulatory response, not enough food or a combination o f both. An additional cause 
of hypoglycaemia is exercise which has its own associated risks.
2.4.2 Definition, symptoms and causes of hyperglycaemia
On the other end of the glycaemic spectrum are elevated levels o f blood glucose known as 
hyperglycaemia. Hyperglycaemia is generally classified as a level of blood glucose above 
euglycaemia ( 4 - 8  mmol L '1), and can be defined as higher than 11 mmol L '1 in experimental 
induced scenarios where blood glucose is manipulated by the use o f hyperglycaemic clamps 
or when blood glucose values are self-reported (Cox et al., 2005; Jenni et al., 2008; Stettler et 
al., 2006).
The symptoms of hyperglycaemia can be categorised into four groups; agitation, osmotic, 
neurological and malaise. Agitation symptoms include feeling tense, restlessness and poor 
concentration, whilst thirst, dry mouth, need to urinate and a sweet taste sensation are 
classified as osmotic symptoms, dizziness, light-headedness and blurred vision are defined as 
neurological symptoms and feelings of malaise include headache and nausea (Warren et al., 
2003). Furthermore, hyperglycaemic blood glucose levels over a prolonged period o f time 
can cause either acute or long term complications. Elevated blood glucose levels are an 
independent and clinically significant risk factor for cardiovascular disease (Gerich, 2003) 
and given that coronary artery disease is the leading cause of death in T1DM strict glycaemic 
control is of great importance and consideration (Conway, Costacou & Orchard, 2009). 
Further complications related to sustained levels o f hyperglycaemia include hypertension, 
sudden death, reduced exercise capacity, neuropathy, nephropathy, retinopathy and even 
blindness, all o f which are further worsened with poor glycaemic control (Peirce, 1999) and 
increase both an individual’s morbidity and mortality (Conway et al., 2009; Khan & Pessin, 
2002)
Insulin, as previously discussed is a key player in glucoregulation and is an essential 
component in the postprandial state. In healthy individuals, as blood glucose levels start to
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rise, insulin is released by the pancreas which in turn promotes glucose uptake into adipose 
and muscle for storage as intracellular triglycerides and glycogen (Khan & Pessin, 2002). 
Glucose uptake in adipose and muscle tissues is insulin-stimulated through a complex 
pathway proceeding through the insulin receptor tyrosine kinase, where the main effect is to 
promote the movement of GLUT-4 receptors from intracellular storage sites to the plasma 
membrane (Khan & Pessin, 2002). In addition to stimulated glucose uptake, insulin also 
inhibits the production and release of glucose from the liver (Khan & Pessin, 2002). 
Therefore, this fine equilibrium of inhibition and stimulated glucose uptake is lost in T1DM 
individuals as with insulin being exogenously administered, circulating insulin levels do not 
change and individuals can be susceptible to elevated levels of blood glucose, especially in 
the postprandial state.
Hyperglycaemia simplistically is a result of too little insulin, too much food (especially 
carbohydrate) or a combination of both and as with hypoglycaemia, exercise is also a risk 
factor for hyperglycaemia.
2.4.3 Glycaemic responses and risks associated with exercise
Engaging in exercise can have impacts on levels of glycaemia either lowering blood glucose 
and increasing the risk of hypoglycaemia or elevating levels of blood glucose and raising the 
possibility of hyperglycaemia.
Risks of hypoglycaemia associated with exercise following exogenous insulin administration 
have always been apparent and were first documented by Lawrence (1926). Lawrence 
discovered that the effects of insulin on blood glucose were increased when an individual 
engaged in exercise over a 2 hour 30 minute period in comparison to no exercise taking 
place. The insulin effects were so greatly increased that blood glucose fell to levels of 
hypoglycaemia in the studied individual. Hypoglycaemia in exercise is generally attributed to 
insulin being exogenously administered, due to this administration it does not decrease at the 
beginning of exercise as it would in healthy individuals. No decrease in circulating insulin 
combined with an insufficient glucagon response results in an unchanged insulin to glucagon 
ratio, which in turn increases the risk that hepatic glucose production will not increase to 
match the increased fuel requirement of exercise (Lumb & Gallen, 2009). In addition there is 
a reversal o f the usual portal to systematic insulin ratio and a relatively higher insulin
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concentration in the periphery ensues (Lumb & Gallen, 2009), this concentration promotes 
peripheral muscle glucose uptake, further reducing levels of glycaemia and increasing the 
chances of hypoglycaemia (Goodyear & Kahn, 1998).
Associated risks can be completed further as different types of exercise result in different 
glycaemic responses. It is generally documented that participation in moderate intensity 
aerobic exercise results in a decline in blood glucose levels (Tsalikian et al., 2005; Tansey et 
al., 2006; West, Morton, Bain, Stephens & Bracken, 2010) with individuals more susceptible 
to hypoglycaemia 20 -  60 minutes after the onset of exercise (Riddell, Bar-Or, Ayub, Calvert 
& Heigenhauser, 1999). In comparison to continuous moderate intensity aerobic exercise, the 
drop in blood glucose has been found to be less after completion of high intensity intermittent 
exercise (Guelfi, Jones & Fournier, 2005). The decline in blood glucose after 30 minutes of 
high intensity intermittent exercise was 2.9 ± 0.8 mmol L '1, whilst blood glucose fell 4.4 ± 1.2 
mmolL"1 after completion of 30 minutes of continuous exercise. In a later publication 
(Guelfi, Ratnam, Smythe, Jones & Fournier, 2007), the authors suggested that the lesser 
declines previously reported could be credited to a greater increase in endogenous glucose 
production and attenuated glucose utilisation during exercise with the attenuation of glucose 
utilisation persisting through to stages of early recovery.
Performing a 10 second maximal sprint after a bout of moderate intensity exercise has been 
proven to prevent the continuing fall in glycaemia for a 120 minute recovery period (Bussau, 
Ferreira, Jones & Fournier, 2006). The observed stability of blood glucose levels was 
accompanied with increased levels of catecholamines, growth hormone and cortisol (Bussau 
et al., 2006). Carrying out the same maximal sprint method prior to engaging in moderate 
exercise does not prevent the continuous fall in glycaemia, however for 45 minutes after 
cessation of exercise glycaemia remained stable (Bussau, Ferreira, Jones & Fournier, 2007). 
In this instance the glycaemic stability was attributed to elevated blood lactate and 
noradrenaline levels (Bussau et al., 2007). However, exercising at high intensity raises the 
possibility of hyperglycaemia during and after exercise even in those individuals that have 
good glycaemic control (Mitchell, Abraham, Schiffrin, Leiter & Marliss, 1988). 
Hyperglycaemia during exercise results from an increased release o f catecholamines, leading 
to the rise in hepatic blood glucose production that exceeds the rate of utilisation (Mitchell et 
al., 1988). Unlike their healthy counterparts, insulin levels do not increase following exercise 
leading to the occurrence of post-exercise hyperglycaemia (Lumb & Gallen, 2009) and there
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has been some suggestion that administering corrective units of insulin following high 
intensity exercise may mimic the insulin responses in non-diabetic individuals (Riddell & 
Perkins, 2009). Adaptations to a sprint training program over 7 weeks have been shown to 
reduce both glycolytic rate and metabolic destabilisation in T1DM individuals suggesting 
increased muscle oxidative metabolism (Harmer et al., 2008), which in turn may help to 
decrease the possibility of developing hyperglycaemia. Even the stress and/or anticipation of 
competition can increase the potential o f hyperglycaemia (Riddell & Perkins, 2009).
Glucose levels need to be monitored following exercise due to the possible risk of late onset 
post exercise hypoglycaemia (LOPEH) that has been documented, usually occurring at night 
and 6 - 1 5  hours after cessation of exercise (MacDonald, 1987). Sustained increase of insulin 
sensitivity in the tissues and the need of the body to replenish muscle glycogen stores offer an 
explanation for LOPEH (Grimm, 2005). Muscle glycogen storage is attributed to GLUT-4 
transporters which have been shown to be increased in expression for at least 3 hours 
following exercise, regardless of the exercise intensity performed (Kraniou, Cameron-Smith 
& Hargreaves, 2006). A further complication is that counter-regulatory responses to 
hypoglycaemia are blunted rapidly following exercise (Sandoval, Aftab Guy, Antoinette 
Richardson, Ertl & Davis, 2006) with this impairment potentially lasting for up to 24 hours 
(Sandoval, Aftab Guy, Antoinette Richardson, Ertl & Davis, 2004). As a result o f the blunted 
counter-regulatory responses there has also been a suggestion of a vicious cycle between 
regular exercise and episodes of hypoglycaemia (Ertl & Davis, 2004). Another complication 
is that warning indications associated with the early stages of hypoglycaemia such as 
sweating, dizziness and tiredness have the possibility o f being masked by the physiological 
responses of engaging in exercise (Lumb & Gallen, 2009; Riddell & Perkins, 2009).
Limited research has been performed in regards to glycaemic responses after completing a 
bout of progressive, incremental, submaximal exercise in T1DM individuals. Incremental 
exercise would incorporate all exercise intensities, beginning at a low intensity and finishing 
at a high, but not maximal exercise intensity. Theoretically, all blood glucose responses 
described previously could be observed in such an exercise protocol.
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2.5 Strategies to reduce incidences of hypoglvcaemia during and after exercise
Current strategies to reduce hypoglycaemic incidences during and post exercise are to reduce 
the pre-exercise insulin doses and/or ingest simple carbohydrates prior to engaging in 
exercise (Riddell & Perkins, 2006; Lumb & Gallen, 2009; Perry & Gallen, 2009). 
Periodically testing blood glucose levels every 30 minutes of exercise is also recommended 
with 20 -  60 g simple carbohydrate supplementation if necessary (De Feo et al., 2006). A 
limitation to these recommendations could be the lack o f focus on limiting hyperglycaemia 
which can be as equally detrimental to the health of individuals and potentially even more so 
long-term as hypoglycaemic episodes. However, there are no specified recommendations in 
regards to insulin dosage or amount of carbohydrate to be consumed and the main strategy 
should be on the individual to monitor their own blood glucose and familiarise themselves 
with their own responses to exercise (Perry & Gallen, 2009). The next few chapters discuss 
the current literature surrounding which strategies to adopt in T1DM individuals.
2.5.1 Manipulation of pre-exercise insulin doses
Lawrence (1926) first suggested that insulin administered prior to exercise should be reduced, 
in turn lowering the risk of hyperinsulinemia in the exercising individual with observed 
decreases in glycaemia theoretically being similar to those levels if the individual had not 
engaged in exercise but administered their normal insulin dose. Many studies have 
investigated the optimum pre-exercise reduction in insulin that effectively regulates blood 
glucose. Strategies adopted ranged from 10 -  30% (Grimm, Ybarra, Berne, Muchnick & 
Golay, 2004), 10 - 40% (De Feo et al., 2006), 50 -  75% (Rabasa-Lhoret, Bourque, Ducros & 
Chiasson, 2001) to 50-90% decreases (Mauvais-Jarvis et al., 2003) in insulin doses. However 
a recent publication by West et al. (2010) concluded that a 75% reduction in rapid-acting pre­
exercise insulin improved blood glucose responses for up to 24 hours after exercise compared 
to an administered full, 25% or 50% reduced dose. Suspending basal insulin infusion 
completely at the start o f exercise has also been shown to reduce the incidence of 
hypoglycaemia during exercise (Tsalikian et al., 2006). Reasons for strategic variations 
adopted in the literature can be influenced by a number o f factors including insulin regimen, 
insulin pharmacokinetics and intensity of exercise, furthermore the timing o f the administered 
insulin dosage is also worthy of consideration.
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Table 2.1 Existing insulin reduction strategies and associated glycaemic responses
Research Insulin Insulin Blood Glucose
(Author, Year) Strategy Regimen Responses
Grimm et al., Reduction of 2x NPH Injections CHO and Insulin reduction
2004 daily insulin dose and strategies were more protective than
by more than 10% 3x Pre-prandial rapid either no CHO and insulin
with or without acting insulin doses adaptations or insulin reduction
CHO provision alone
Mauvais-Jarvis Either 50% Either 2x Regular In reduction trials BG was
et al., 2003 reduction (2x Insulin injections and maintained to near euglycaemic
injections) OR lx  Mixed Reg/NPH levels.
90% reduction injection OR In trials where no reductions took
(3x injections) 2x (30% Reg/70% 
NPH) injections
place 66% of participants suffered 
hypoglycaemia
Rabasa-Lhoret Either Full dose, Basal-bolus regimen. Full dose increased risk of
et al., 2001 50% or 75% lx  Ultralente (basal) hypoglycaemia at all exercise
reduction of bolus injection and 3x intensities in comparison to
insulin and 600 lispro (bolus) reductions.
kcal breakfast injections 75% reduction resulted in increased
meal (75 g CHO) blood glucose from baseline 
following exercise
West et al., Either Full dose, Basal-bolus regimen. Pre-exercise blood glucose values
2010 25%, 50% or 75% lx  glargine (basal) increased as insulin doses decreased
reduction of bolus injection and either Blood glucose declined in all
insulin and 1.12 3x lispro OR 3x conditions following 45 min run at
mJ meal (60 g aspart injections 70% VO2 PEAK-
CHO) Full dose -  6.1; 75% Dose -  4.3; 
50% Dose -  5.5; 25% Dose -  3.2 
mmolL'1.
21 hour blood glucose area under 
the curve greater after 50% and 75% 
reductions.
Suggested reductions (Table 2.1) were either to reduce regular or rapid-acting doses (De Feo 
et al., 2006), reduce both rapid acting and intermediate neutral protamine Hagedom (NPH) 
analogues (Grimm et al., 2004), manipulation of either an injection of regular insulin or
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combined insulin (30% regular/ 70% NPH) dose (Mauvais-Jarvis et al., 2003) or reduced 
doses of bolus injections in basal-bolus regimens treated intensively with either insulins 
ultralente as basal and lispro (Rabasa-Lhoret et al., 2001) or insulin glargine as basal and 
insulin lispro or insulin aspart (West et al., 2010). The reasoning behind insulin reductions is 
predominately two-fold, firstly to prevent the potential for over-insulinisation during exercise 
and secondly to elevate blood glucose levels to compensate for any exercise-induced falls in 
glycaemia. Therefore, the larger the reductions in pre-exercise insulin dosage, the higher the 
blood glucose values are prior to the onset o f exercise (West et al., 2010). Nevertheless it is 
worth considering that reducing pre-exercise basal insulin can cause pre-exercise and late 
post-exercise hyperglycaemia, whilst reducing basal doses are unsuitable for late postprandial 
activities (Lumb & Gallen, 2009).
Moreover, the dynamics and pharmacokinetics o f insulins aspart and lispro are considered 
similar with both equally effective at controlling postprandial blood glucose excursions 
(Plank et al., 2002), and also the metabolic influences on correcting fat and carbohydrate 
abnormalities are indistinguishable between insulins (Homko, Deluzio, Jimenez, Kolaczynski 
& Boden, 2003). Aspart and lispro both differ from human insulin, with a single substitution 
of proline with aspartic acid in position B28 and the substitution of proline with lysine in 
position 28 and vice-versa in position 29 of the B chain in aspart and lispro respectively. 
These alterations increase the rate of absorption as the analogues are less likely to convert 
into dimmers and hexamers (Homko et al., 2003). Insulin pump therapy aside, basal-bolus 
regimens are generally recommended for exercising individuals with T1DM (Gallen, 2005; 
Grimm, 2005).
Duration and intensity of exercise performed must also be taken into account when 
manipulating insulin doses, as discussed previously (Chapter 2.4.2) different exercise 
intensities result in different glycaemic responses. The larger 75 -  90% insulin reductions 
(Rabasa-Lhoret et al., 2001; Mauvais-Jarvis et al., 2003; West et al., 2010) were administered 
prior to engaging in continuously aerobic exercise, intensities ranging from 25 -  75%
VO2 max  and lasting between 30 -  60 minutes in duration. Grimm et al., (2004) suggested to 
only reduce insulin doses if exercising for over 20 minutes at a higher intensity (> 7 5 %  
maximum heart rate (MHR)) or for prolonged periods (> 60 minutes) of moderate intensity 
exercise (60 -  75% MHR), no alterations in insulin doses was recommended for lower
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intensity exercise (< 60% MHR). The recommendations by Grimm et al. (2004) were largely 
based around carbohydrate consumption alongside insulin reductions for the different 
exercise intensities.
Insulin administration and timing o f subsequent exercise is of important consideration. Time 
to peak serum insulin levels are quicker in newer rapid-acting analogues, reaching peak 
values at 30 -  45 minutes following administration (Plank et al., 2002). Exercise should 
therefore be performed when insulin action is on the decline with current suggestions being 3 
-  4 hours following regular insulin administration and 2 hours after rapid-acting injections 
(De Feo et al., 2006). Allowing this sufficient time before exercise diminishes the risk o f over 
over-insulinisation of the active musculature during exercise (De Feo et al., 2006; Perry & 
Gallen, 2009). Conversely, most recent literature has established that administration of low 
doses of rapid-acting insulin combined with carbohydrate ingestion 30 minutes prior to 
exercise can reduce incidences of hypoglycaemic episodes rather than increase the risk of 
developing exercise-induced hypoglycaemia (West et al., 201 la).
With a number of recommendations (Grimm et al., 2004; West et al., 2010; West et al., 
2 0 1 1 a) also accounting for carbohydrate consumption it appears that a combined 
management strategy of insulin reduction together with carbohydrate intake is a more 
sensible and viable option.
2.5.2 Carbohydrate ingestion
2.5.2.1 Amount of carbohydrate
Unfortunately the risk of hypoglycaemia cannot be simply resolved by ingestion of 
carbohydrate to significantly elevate levels o f blood glucose. Increased amounts of 
carbohydrate ingestion in combination with lowered insulin doses can lead to hyperglycaemia 
which as discussed previously prolonged durations o f elevated blood glucose have their own 
risks for the exercising individual (Chapter 2.4.2).
In reference to the amount of carbohydrate needed to fuel exercise and prevent 
hypoglycaemia, the information supplied in the guidelines is limited. With blood glucose 
responses to exercise being individualised, this is reflected somewhat in the current
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guidelines, as carbohydrate is recommended to be consumed as required (Zinman et al, 
2004). Suggested amounts o f carbohydrate to be consumed prior to exercise range from 20 -  
60 g (De Feo et al., 2006), 30 g (Grimm et al., 2004), 40 g (Dube, Weisnagel, Prud’homme & 
Lavoie, 2005), 75 g (West et al., 201 la; West et al., 201 lb) up to 1 g'kg' 1 B M h ' 1 (Hernandez, 
Moccia, Fluckey, Ulbrecht & Farrell, 2000). Matching the amount of carbohydrate ingested 
with the carbohydrate utilised during exercise has also be shown to attenuate hypoglycaemia 
(Riddell et al., 1999) and this method has also been remarked as the most important pre­
exercise prevision to safeguard against hypoglycaemia (Grimm et al., 2004). Considering 
exercise duration and intensity, Kordi and Rabbani (2007) composed a table from the data 
collected by a number of authors, (Moriarity, 1997; Brown & Wilson 2000; Birrer & 
Sedaghat 2003). The collated data recommended from a safety point of view that depending 
on blood glucose concentrations, 10 -  15 g carbohydrate should be consumed for low 
intensity, short duration exercise, 10 -  50 g carbohydrate for moderate intensity, moderate 
duration exercise, and 30 -  50 g carbohydrate would account for high intensity, moderate 
duration exercise with no carbohydrate supplementation required for high intensity, short 
duration exercise.
Hernandez and colleagues (2000) also commented that 1 g kg ' 1 BM h ' 1 was also enough 
carbohydrate to benefit performance, even values o f 1 -  2 g'kg ' 1 BM consumed 1 hour prior 
to exercise have been recommended to enhance performance as this maximises pre-exercise 
glycogen values and therefore providing energy for oxidation (Riddell & Perkins, 2006). 
However, in a review article, Jeukendrup (2004) concluded that ingestion o f carbohydrate 
greater at a value greater than 75 g h ' 1 did not appear to improve performance when compared 
to amounts ranging from 45 -  75 g h '1. In the same article, the author recommended that 
carbohydrate ingestion of 1 . 0  -  1 . 1  g per minute during exercise would maximise 
performance.
Delivery of carbohydrate is usually provided in a liquid form prior to or during exercise in 
research trials (Perrone, Laitano & Meyer, 2005; West et al., 2011a; West et al., 2011b). 
Again within this literature there are disparities within concentrations of these drinks, it has 
been suggested that a 6 % carbohydrate-electrolyte beverage may have better absorption rates 
than higher concentrated beverages which may delay gastric absorption and cause stomach 
upset (Riddell & Perkins, 2006). Although, in other research four individuals had to withdraw 
from exercise after consumption of an 8 % solution as a result of declining blood glucose
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levels (Perrone et al., 2005). Fluid concentrations of 10% carbohydrate solution have been 
demonstrated to prevent hypoglycaemia during and after exercise (Perrone et al., 2005; West 
et al., 2011a; West et al., 2011b). Furthermore, no gastrointestinal symptoms were reported 
and participants kept euhydrated throughout (Perrone et al., 2005), the better hydration of 
these individuals is due to more fluid being retained in drinks with higher carbohydrate 
concentrations (Evans, Shirreffs & Maughan, 2009).
The type of carbohydrate recommended to reduce the potential of developing hypoglycaemia 
is usually referred to as simple which is a categorisation normally associated with the 
glycaemic index.
2.5.2.2 Glvcaemic index (GI) of carbohydrates
The glycaemic index (GI) was a concept first introduced in 1981 by Jenkins and colleagues 
categorised on postprandial blood glucose responses after ingestion of foodstuff in direct 
comparison to the responses after ingestion of an identical amount of a reference food usually 
either white bread or glucose. Research has continued in this discipline to the present day and 
lists are being compiled and constantly updated to account for most commercially available 
food products (Foster-Powell, Holt & Brand-Miller, 2002; Henry, Lightowler, Strik, Renton 
& Hails, 2005; Atkinson, Foster-Powell & Brand-Miller, 2008). A table compiled of 
everyday foodstuffs and their glycaemic index values is detailed below (Table 2.2).
Table 2.2 Everyday foodstu ff and respective glycaemic index values (Atkinson et al., 2008)
Foodstuff Glycaemic Index (GI)
Dextrose (Glucose Powder) 100
Cornflakes 81
White Bread 75
Potato Crisps 56
Sweet Com 52
Lentils 32
Isomaltulose 32
Kidney Beans 24
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Carbohydrates are normally termed simple or complex according to their chemical structure 
(O’Reilly, Wong & Chen, 2010). Simple carbohydrates are usually high GI, contain mono-, 
di- or oligo-saccharides and thought unhealthy whilst complex carbohydrates are generally 
considered healthier containing starches or polysaccharides and calculated as low GI (Venter, 
Slabber & Vorster, 2003). This is maybe an unfair generalisation as glycaemic responses can 
also be influenced by other factors such as food processing (Brand, Nicholson, Thorbum & 
Truswell, 1985), particle size or the cooking of starch foodstuff which splits the granules, 
increasing the availability to amylase (Codings, Williams & MacDonald, 1981). Exceptions 
to this loose terminology include French fries that are deemed ‘complex’ but are high in fat 
while healthy options that provide vitamins and protein such as yoghurt and fruit are 
classified as ‘simple’ (O’Reilly et al., 2010). The glycaemic index of carbohydrates can also 
have an effect on digestion rates. Monosaccharides are o f a molecular size that easily permits 
the crossing of the mucosal cell membrane by simple diffusion and passive diffusion down a 
concentration gradient is one explanation of absorption, whilst on the other hand 
disaccharides are too large and require hydrolysis to cross the mucosal cell membrane 
(Southgate, 1995).
Incorporating low GI foods (e.g. brown basmati rice, peaches, kidney beans) into daily diets 
of T1DM individuals as opposed to higher GI foodstuff (e.g. white bread, mashed potatoes, 
cornflakes) has shown to reduce peak blood glucose and daytime mean blood glucose values 
with no difference in nadir or nocturnal blood glucose levels. These reductions in blood 
glucose excursions benefited glycaemic control with concentrations within a target range of 
3.9 -  9.9 mmol L ' 1 for longer periods of time and less bolus insulin required per 10 g of 
carbohydrate (Nansel, Gellar & McGill, 2008). Another 12 month intervention study 
(Gilbertson et al., 2001) observed improved HbAjc scores with no increased risk of 
hypoglycaemia and enhanced quality of life after adherence to a diet emphasised on low GI 
foods. Moreover, selecting low GI foodstuff as an alternative to conventional meals has a 
small but clinical benefit similar to that of pharmacological therapies that combat 
postprandial hyperglycaemia (Brand-Miller, Hayne, Petocz & Colagiuri, 2003).
A low GI or low GI with added sucrose breakfast as opposed to a high GI breakfast results in 
a significantly lower energy intake at lunchtime (Warren, Henry & Simonite, 2003). This 
effect only appeared to be a short-term benefit for that day as over a long-term study of ten 
weeks no significant difference was found after low GI breakfasts, although daily energy
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intake tended to be less (Henry, Lightowler & Strik, 2007). Cognitive performance has also 
been evidently sustained after a low GI breakfast with individuals achieving greater memory 
and accuracy scores in tasks towards the latter stages of the morning period (Benton et al., 
2003; Ingwersen, Defeyter, Kennedy, Wesnes & Scholey, 2007). Additionally, consumption 
of low GI meals for both breakfast and lunch can also decrease hunger ratings for a 3 hour 
postprandial period following lunch (Stevenson, Williams & Nute, 2005), with increased 
ratings of satiety reported after low GI meals it has been further speculated that long term 
adoption of this strategy may reduce caloric intake and therefore benefit weight loss and/or 
control (Ball et al., 2003).
One such example of a low GI foodstuff that has been used in diet intervention studies 
(Holub et al., 2010) and also supplied as a pre-exercise drink to avoid hypoglycaemia (West 
et al., 201 la, West et al., 201 lb) is isomaltulose (Palatinose®, Beneo Group, Germany).
2.5.2.3 Isomaltulose
This naturally occurring disaccharide (chemical name: 6 - O - a - D  -  glucopyranosyl -  D -  
fructofuranose) found in honey, is composed of glucose and fructose linked by a a  -  1 , 6  
glycosidic bond (Lina, Jonker & Kozianowski, 2002). Commercially available isomaltulose 
(Palatinose®) derived from food grade sucrose and manufactured by enzymatic 
rearrangement of ( l , 2 )-fructoside to ( l , 6 )-fructoside has been used as sugar replacement in 
Japan and other Asian countries for over twenty years (Holub et al., 2010; Lina et al., 2002). 
In the latest published tables (Atkinson et al., 2008; Table 2.1) isomaltulose has been 
calculated to have a glycaemic index value of 32 and therefore classified as very low GI. The 
associated decreased insulin and blood glucose responses with isomaltulose are 
characteristics particularly desirable to individuals with diabetes (Kawai, Yoshikawa, 
Murayama, Okuda & Yamashita, 1989). Isomaltulose is hydrolysed in the same manner as 
sucrose by the active site o f isomaltase in the sucrose-isomaltase complex and absorbed in the 
small intestine (Goda & Hosoya, 1983). Once hydrolysed the resultant glucose and fructose 
are digested through classical processes (Lina et al., 2002). During this digestion period 
fructose bypasses the phosphofructokinase regulatory point in glycolysis which leads to an 
increased flux through the glycolytic pathway that in turn leads to an accumulation and 
subsequent release of lactate (Kaye, Williams & Barbero 1958; Sahebjami & Scalettar 1971). 
Although the chemical composition of isomaltulose and sucrose are somewhat similar, a 1,6
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glycosidic bond between glucose and fructose in isomaltulose as opposed to 1 , 2  in sucrose 
there are many differences between the two sugars. Research has shown that hydrolysis of 
disaccharides with a - 1 , 6  glycosidic bonds is much slower than disaccharides with either a - 1 , 2  
or a -1,4 glycosidic bonds (Gunther & Heymann, 1998). However, even though these 
hydrolysis rates are slower in isomaltulose, it has been commented that 50 g can be ingested 
without any gastrointestinal discomfort (Lina et al., 2002).
During exercise the oxidation rates are lower in isomaltulose compared to sucrose with peak 
and mean oxidation 42% and 50% lower respectively, resulting in a 59% lower oxidation rate 
overall (Achten, Jentjens, Brouns & Jeukendrup, 2007). These lesser oxidation rates were 
mainly credited to the slower hydrolysis, therefore reducing the absorption rate o f 
metabolised fructose and glucose and subsequently decreasing the rates of oxidation (Achten 
et al., 2007). Additional research (van Can, Ijzerman, van Loon, Brouns & Blaak, 2009) 
comparing these two sugars in healthy, overweight individuals observed a 14% increase in 
postprandial fat oxidation after isomaltulose ingestion whilst further witnessing lower insulin 
responses and lesser excursions in blood glucose. An increased reliance on lipid oxidation 
during subsequent exercise following isomaltulose consumption can also improve post­
exercise glycaemia in T1DM individuals as discussed later (West et al., 2011b; Chapter 
2 .6 .2).
2.6 Substrate utilisation during exercise
The four main components to fuel exercise in healthy individuals are muscle glycogen, 
muscle triglycerides, plasma free fatty acids and plasma glucose, the utilisation of these four 
components vary depending on the intensity o f exercise performed (Romijn et al., 1993). 
However, in T1DM individuals there is more reliance in oxidation of glycogen stores in 
either the liver or muscle, with a compensatory increase reported in muscle glycogen 
utilisation rather than plasma glucose oxidation to fuel exercise (Robitaille et al., 2007).
2.6.1 Exercise intensity
An increase in exercise intensity typically results in more reliance on oxidation of 
carbohydrates to fuel the exercise as individuals cannot oxidise lipids fast enough to provide 
sufficient energy at these increasing intensities (Coyle, 1995). Carbohydrates are stored in the
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body as glycogen in either the muscles or liver and during high intensity exercise energy is 
primarily supplied by carbohydrate oxidation predominantly via breakdown of these 
glycogen stores (Coyle, 1995).
The regulation and reliance on carbohydrates is relatively well understood, however the 
regulation and utilisation of lipid as a fuel is less clear. There are suggestions that lipid 
oxidation is regulated directly by carbohydrate availability (Coyle, Jeukendrup, 
Wagenmakers & Saris, 1997) or that there is a ‘crossover’ concept where at a certain exercise 
intensity the energy derived is equal between both carbohydrates and lipids but beyond this 
point carbohydrate is the dominant substrate (Brooks & Mercier, 1994). Lipid oxidation can 
also be influenced by repeated bouts of exercise, following an initial exercise bout, exercise- 
induced increases in extracellular glycerol concentrations in adipose tissue and plasma 
glycerol concentrations were both higher in a second exercise bout (Stich et al., 2000). 
Repetitive bouts also enhance fat metabolism compared with a single bout of exercise at the 
equivalent total duration of exercise (Goto, Ishii, Mizuno & Takamatsu, 2007).
Recently there has been an emerging focus that has investigated the exercise intensity that 
promotes the peak rates of lipid oxidation, commonly referred to as ‘fatmax’ (Jeukendrup & 
Achten, 2001). The intensity value that has been documented to induce maximal levels of fat
oxidation are 64 ± 4% VO2 m ax  which is equivalent to 74 ± 3% maximum heart rate in non­
diabetic individuals (Achten, Gleeson & Jeukendrup, 2002). This intensity was determined by 
an incremental protocol which lasted 3 minutes although no differences were found in 
increments lasting for 5 minutes (Achten et al., 2002). Previous research (Bergman & 
Brooks, 1999; Romijn, Coyle, Sidossis, Rosenblatt & Wolfe, 2000; van Loon, Greenhaff, 
Constantin-Teodosiu, Saris & Wagenmakers, 2001) that investigated substrate utilisation at 
differing exercise intensities over prolonged durations which lasted between 30 -  120 min 
also witnessed peak rates of lipid oxidation at comparable exercise intensities. Further 
research (Bircher, Knechtle & Knecht, 2005) measured blood lactate concentrations at fatmax 
using both a standard protocol as defined by Achten et al. (2001) and an individualised 
exercise program tailored to the participant. Blood lactate concentrations at fatmax were 
found to be between 1.06 -  1.18 and 1.98 -  2.19 mmolL ' 1 in the standard and individual 
protocols respectively. However, the reliability of fatmax has also been questioned and 
documented large individual variability imply that a definitive exercise intensity cannot be
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designated for exercise prescription in regards to health benefits (Meyer, Folz, Rosenberger 
& Kindermann, 2009).
Direct comparison between non-TlDM  and T1DM individuals has proven that after pre­
exercise glucose feeding and engagement in moderate intensity exercise, substrate and 
exogenous glucose oxidation was similar, however, plasma glucose oxidation was lower in 
T1DM which is associated with a compensatory increase in muscle glycogen utilisation 
(Robitaille et al., 2007). A further consideration with exercising T1DM and substrate 
utilisation is levels of glycaemia. Performing a prolonged period of exercise in levels of 
hyperglycaemia (clamped at 11 mmol L '1) has been demonstrated to suppress lipid oxidation 
with a tendency to favour carbohydrate oxidation compared to euglycaemia (Jenni et al.,
2008). Carbohydrate oxidation in hyperglycaemia is also elevated above those oxidation 
levels observed in a controlled level with blood glucose concentrations at 10.8 ± 0.4 and 4.2 
± 0.2 mm olL ' 1 respectively, whilst hyperglycaemia can also promote increased glucose 
disposal rates (Coyle, Hamilton, Gonzalez Alonso, Montain & Ivy, 1991).
2.6.2 Ingestion of pre-exercise carbohydrates with differing GI values
The manipulation of pre-exercise carbohydrate ingestion with different glycaemic indexes 
was carried out first by Thomas, Brotherhood & Brand (1991) who observed after 
consumption of lentils in comparison to other foodstuff, participants increased their cycling 
endurance by up to 20 minutes. Further literature in non-TlDM  participants (Febbraio, 
Keenan, Angus, Campbell & Gamham, 2000; Wee, Williams, Tsintzas & Boobis, 2005; Wu, 
Nicholas, Williams, Took & Hardy, 2003) demonstrates that high glycaemic index 
carbohydrates augments muscle glycogen utilisation during subsequent exercise and 
therefore, when a low glycaemic index carbohydrate is consumed prior to exercise exogenous 
and endogenous carbohydrate is spared due to increased fat oxidation during exercise.
The ingestion of different GI carbohydrates prior to exercise in T1DM individuals has 
recently been investigated (West et al., 2011b), where isomaltulose (low GI) was consumed 
2-hours prior to 45 minutes of running exercise as an alternative to dextrose (high GI). Levels 
of glycaemia were significantly improved for a 3-hour recovery period in the isomaltulose 
trial alongside a significant increase in lipid oxidation and significant decrease in 
carbohydrate oxidation during the final ten minutes of exercise when compared to dextrose.
24
This increased reliance on lipids to fuel exercise and reduced carbohydrate oxidation could 
explain the reduced excursions in blood glucose responses and regularly employing this 
strategy has the potential to benefit long-term glycaemic control. Current recommendations 
(Lumb & Gallen, 2009) promote consumption of high GI carbohydrates before exercise to 
reduce the incidence of hypoglycaemia whilst low GI consumption has been shown in the 
research of West et al. (201 lb) to be as equally effective.
The duration of exercise could be an important consideration in the research o f non-TlDM  
and T1DM individuals as mentioned the dominant fuel use only shifted in the final ten 
minutes of a 45 minute protocol in T1DM (West et al., 201 lb) and in non-TlDM  the duration 
of exercise was at least 30 minutes long. One of the unanswered questions within the research 
of West et al. (2011b) is whether the lower blood excursions reported would impact upon 
subsequent exercise performance. At present there is little research investigating performance 
in T1DM individuals, with a body of evidence suggesting performance being improved in 
non-TlDM due to carbohydrate sparing, it warrants examining the performance effects after 
ingestion of differing GI pre-exercise carbohydrates. Greater reliance on lipid oxidation 
during submaximal exercise may benefit later performance or it could be that performance is 
compromised for the better glycaemia in T1DM individuals following low GI 
supplementation.
2.7 Exercise performance
2.7.1 Methods to measure performance
Testing performance is one o f the most important factors in sports science and physiology 
(Currell & Jeukendrup, 2008) with two commonly used examples to measure exercise 
performance being time to exhaustion (TTE) and time trial (TT) protocols (Laursen, Francis, 
Abbiss, Newton & Nosaka, 2007). Both of these methods were adopted in some of the 
previously discussed glycaemic index performance interventions (Sparks et al., 1998; 
Thomas et al., 1991; Wong et al., 2008; Wu & Williams, 2006).
TTE trials involve an individual to exercise until volitional exhaustion at a given intensity 
and are sometimes referred to as a measure of endurance capacity (Currell & Jeukendrup,
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2008). On the other hand, TT experiments require an individual to complete a set distance or 
workload as quickly as possible or the measurement of distance covered within a defined 
time limit. Using TT assessment allows the participants to adjust their workload periodically 
and pace themselves accordingly to the previously notified endpoint (Tucker & Noakes,
2009).
One limitation with the TTE model is the perceived low reliability of the test procedure 
which is reflected in high co-efficient o f variation (CoV) values. Typically, TTE experiments 
can result in CoV of between 13 .2-15 .1%  even as high as 26.6% (Jeukendrup, Saris, Brouns 
& Kester, 1996), CoV scores between 2.0 -  3.6% were reported in TT protocols (Jeukendrup 
et al., 1996; Laursen et al., 2007). These lower CoV values in TT compared to TTE has 
resulted in this protocol to be claimed a more validated method to measure performance 
(Jeukendrup et al., 1996).
However more recently, TTE methods have been defended by some researchers (Hopkins, 
Schabort & Hawley, 2001) who claim that the high CoV in such trials can be influenced by a 
small change in an individual’s ability to output power and the large changes seen in duration 
of time are in addition to a lot more noise. Hopkins et al. (2001) continue and indicate that if 
changes or noise in duration were converted back to changes in mean power over the TTE 
period the CoV would be reduced and the TTE protocol would be more reliable than other 
testing methods.
2.7.2 Factors that impact upon performance
Fatigue is one o f the major contributors that can impair exercise performance, fatigue is 
caused by a number o f factors one of which being glycogen depletion. Carbohydrate 
utilisation has been shown to be correlated with reductions in glycogen stores and concluded 
that the ability to perform high intensity exercise prior to the onset o f fatigue is directly 
determined by availability o f glycogen (Ahlborg, Bergstrom, Ekelund & Hultman, 1967; 
Bergstrom, Hermansen, Hultman & Saltin, 1967). Muscle glycogen stores and subsequent 
availability can decrease performance in both short-term and prolonged intermittent 
assessments (Balsom, Gaitanos, Soderlund & Ekblom, 1999). Depletion o f glycogen stores is 
o f interest in regards to exercising T1DM individuals as there has been shown to be a 
compensatory increase in muscle glycogen utilisation when exercising when directly
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compared to healthy counterparts (Robitaille et al., 2007). This finding may influence the 
choice of carbohydrate ingested prior to or during exercise as it appears that assimilation and 
ability to store as glycogen for oxidation are the most important factors in T1DM.
Carbohydrate ingestion before and during exercise is recommended to improve performance 
as a means to delay glycogen depletion and subsequent fatigue (Coyle, 1995; El-Sayed, 
MacLaren & Rattu, 1997; Jeukendrup, 2004). Carbohydrate feeding may also improve 
endurance performance via a number of other mechanisms of which these include sparing 
endogenous glycogen, synthesising glycogen at low intensity exercise and maintaining both 
high rates of carbohydrate oxidation and levels of blood glucose (Jeukendrup, 2004). Low 
glycaemic index carbohydrates as previously discussed (Chapter 2.6.2) can spare endogenous 
and exogenous carbohydrate through increased rates o f lipid oxidation (Febbraio et al., 2000; 
Thomas et al., 1991; Wee et al., 2005; Wu et al., 2003). Exercise performance may be 
enhanced as a result of this carbohydrate sparing effect as improvements has been observed 
in both time trial (Wong et al., 2008) and time to exhaustion (DeMarco, Sucher, Cisar & 
Butterfield, 1999; Thomas et al., 1991; Wu & Williams, 2006) scenarios following a low GI 
meal. However, there is also evidence that contradicts the performance benefits of low GI 
supplementation where no change in power output was witnessed even though there was 
observed differences in pre-exercise metabolism (Sparks, Selig & Febbraio, 1998). Several 
amounts of carbohydrate have been mentioned to benefit performance with suggestions o f up 
to 1 -  2 g.kg.BM.h’ 1 (Hernandez et al., 2000; Riddell & Perkins, 2006) have been suggested, 
however carbohydrate ingestion over 75 g.h ' 1 does not further enhance performance in 
comparison to provisions of 45 -  75 g.h ' 1 (Jeukendrup, 2004).
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Table 2.3 Existing pre-exercise CHO manipulation and perform ance responses in non T1D M
Study (Author, 
Year)
Substrate Use and/or 
Metabolic Responses
Subsequent
Performance
DeMarco et al., Reduced plasma insulin levels in LGI trial TTE was 59% longer at
1991 RER higher during exercise in HGI trial 100% V 0 2MAxin LGI
Increased plasma glucose following 2 hours of  
exercise in LGI trial
trial
Sparks et al., Increased plasma glucose concentrations at rest No difference in work
1998 and decreased during and after exercise in HGI output during 15 min
trial self-paced performance
Plasma FFA concentrations higher at start and
end of exercise in LGI trial
CHO oxidation higher during exercise in HGI
trial
cycle
Thomas et al., FFA concentrations higher in LGI trial Cycling endurance
1991 Plasma glucose and insulin levels lower in LGI increased by up to 20
trial min after lentil 
consumption
Wong et al., Increased rates o f lipid oxidation during Faster time in 16 km
2008 exercise after LGI meal performance run in LGI 
trial
Wu & Williams, Lipid oxidation during exercise was higher in Greater endurance
2006 LGI trial capacity in TTE 
assessment in LGI trial
KEY: CHO, Carbohydrate; FFA, Free Fatty Acids; HGI, High Glycaemic Index; LGI, Low 
Glycaemic Index; RER, Respiratory Exchange Ratio; TTE, Time To Exhaustion
During high intensity, blood flow and oxygen demand can fall behind the requirements 
needed by the working muscles. To meet the demand the body metabolises anaerobically, 
producing a number of metabolites of which include lactate and hydrogen ions, these ions in 
particular inhibit muscle contraction thus causing fatigue (Noakes, 2000). During incremental 
or graded exercise, muscle contraction alone stimulates glycogenolysis and subsequent 
lactate production (Billat, 1996). The lactate threshold is the exercise intensity performed 
where an individual is exercising below a 1 mmol L’ 1 increase from resting blood lactate 
concentrations (Farrell, Wilmore, Coyle, Billing & Costill, 1979). Exercising at intensities
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higher than this threshold promotes the accumulation of lactate which can result in fatigue. 
Another consideration when measuring blood lactate considerations and exercise in 
carbohydrate supplementation research is that carbohydrate feeding alone promotes 
glycolysis and produces lactate even at rest (Houston, 1995). Decreases in muscle pH are also 
linearly associated with an increase in lactate and pyruvate concentrations (Sahlin, Harris & 
Hultman, 1975).
Aside from lactate concentration, the combination of heat generated through exercise and 
sweat loss can further lead to dehydration (Coyle, 1999) which can also impact upon exercise 
performance. Fluid loss is usually accompanied with a reduction in plasma volume and can 
influence the capacity o f the working muscles as blood flow to the muscles needs to be 
maintained at high levels to provide required oxygen and substrates (Maughan, 2003). 
Research shows that in dehydration the blood flow to the working muscles is decreased as a 
result o f a lowering in systemic blood flow and perfusion pressure (Gonzalez-Alonso, Calbet 
& Nielsen, 1998). Therefore with a restriction of blood flow to working muscles, the 
substrate and oxygen supply is diminished and exercise performance is compromised. Blood 
haematocrit ratio increases continually during heat exposure to levels of dehydration (Senay, 
1970) and is a commonly used marker of hydration status in practical assessments (Harvey, 
Meir, Brooks & Holloway, 2008; Shirreffs, 2003).
An important consideration in exercising T1DM individuals is that some symptoms of 
dehydration (dry mouth and thirst) are also markers of hyperglycaemia (Warren et al., 2003) 
whilst sweating, a physiological response to exercise, is also a hypoglycaemic symptom 
(Deary et al., 1993). The danger is that these warning signs associated with either high or low 
levels of blood glucose could be confused as physiological responses to exercise rather than 
hypo- or hyperglycaemia. Furthermore, exercising in hyperglycaemia has been suggested to 
increase extracellular glucose availability and theoretically increase rates of oxidation. 
Although in reality this availability does not result in the increase of intracellular glucose 
oxidation with lactate, peak power output and respiratory exchange ratio (RER) all equivalent 
in comparison to euglycaemic conditions (Stettler et al., 2006) and therefore no advantage in 
performance in T1DM.
Performance can also be enhanced by the supplementation of caffeine prior to exercise. 
Caffeine ingestion has been shown to improve endurance performance (Costill, Dalsky &
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Fink, 1978; Kovacs, Stegen & Brouns, 1998), caffeine increases lipid oxidation and has a 
positive influence on nerve impulse transmission which could explain the performance 
benefits (Costill et a l, 1978). Therefore caffeine intake would need to be restricted prior to 
any nutritional interventions examining exercise performance such as carbohydrate feeding as 
these results could be influenced by previous caffeine ingestion and not only the carbohydrate 
manipulation.
2.8 Electrolyte responses to exercise
Irrespective of carbohydrate ingestion, electrolytes responses are influenced by exercise and 
associated increased demands of the working muscles. During exercise, an increase in muscle 
contractions is required to perform the workload being demanded. The essential component 
for muscle activation is the uptake o f calcium ions and the subsequent regulation o f the 
contractile processes of muscle through the troponin-tropomyosin (Ebashi, 1972). High 
intensity demanding exercise such as performance bouts have witnessed impaired calcium 
ion uptake and transport which suggests that this may contribute to fatigue (Leppik et al., 
2004).
Blood potassium concentrations are dependent on exercise intensity and increase with higher 
levels o f exercise. The rise in potassium is attributed to the rapid loss of potassium from the 
exercising muscles and release into the blood circulation (Vollestad, Hallen & Sejersted, 
1994). On cessation of exercise the uptake of potassium from the blood is immediate 
(Vollestad et al., 1994) this uptake is principally regulated by the sodium-potassium (Na+ - 
K+) pump in the exercised muscles (Medbo & Sejersted, 1990). Potassium clearance during 
exercise is regulated during exercise via Na+-K+-ATPase in the skeletal muscle where 
potassium is exchanged for sodium, this process is crucial in protecting both muscle 
membrane contractility and excitability (Sejersted & Sjogaard, 2000). Sodium concentrations 
are usually between the normal range of 135 -  146 mmolL ' 1 (Vrijens & Rehrer, 1999). 
During prolonged periods of exercise and via subsequent sweat loss sodium concentrations 
can fall which if not sufficiently replaced with fluid can result in dehydration (Vrijens & 
Rehrer, 1999). Dehydration as previously discussed can impact upon exercise performance, 
therefore both sodium and haematocrit measurements could indicate levels of hydration.
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In specific regards to individuals with T1DM, following intense exercise decreased levels of 
sodium accompanied by elevated potassium concentrations have been observed, the 
potassium levels remaining elevated until insulin is exogenously administered (Harmer et a l, 
2006).
2.9 Cognitive function and levels of glycaemia
Levels of glycaemia is previously discussed can be influenced by engagement in exercise 
(Chapter 2.4.3). Dependent on the exercise performed blood glucose can become elevated 
towards hyperglycaemic levels or start to decline towards hypoglycaemic levels. The next 
chapters discuss how cognitive function can be affected by levels of glycaemia, other 
influences that impact upon cognitive function, a recognised method to test cognitive 
function and primarily by addressing hypoglycaemia unawareness.
2.9.1 Hypoglycaemia unawareness
Hypoglycaemia unawareness is simply the failure to identify hypoglycaemia and commonly 
reflects deficient sympathoadrenal activation (Heller, 2011). Individuals that suffer from 
hypoglycaemia unawareness have no endocrine protection against insulin-induced 
hypoglycaemia, having previous lost their glucagon responses (Heller, 2011). Early warning 
indications of hypoglycaemia such as anxiety and nervousness are caused by the release of 
adrenaline, however these adrenergic responses are not present in hypoglycaemia 
unawareness as adrenaline is impaired (Fowler, 2008). An association between severe 
hypoglycaemia and hypoglycaemia unawareness has been previously documented (Gold, 
MacLeod & Frier, 1994; Mokan et al., 1994), with hypoglycaemia unawareness also 
implying repeated episodes of hypoglycaemia (Cryer et al., 2003). It has been suggested that 
avoidance of hypoglycaemic for a period of 2 -  3 weeks may help to improve hypoglycaemia 
unawareness (Cryer et al., 2003).
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2.9.2 Cognitive function in hypoglycaemia
A number o f studies (Draelos et el., 1995; Evans, Pemet, Lomas, Jones & Amiel, 2000; 
Sommerfleld, Deary, McAuley & Frier, 2003) have investigated cognitive function in 
hypoglycaemia by regulating blood glucose levels using either a hyperinsulinemic (Evans et 
al., 2000; Sommerfield et al., 2003) or hypoglycaemic clamp (Draelos et al., 1995).
Comparisons were made between cognitive function in a series of tests at hypoglycaemia and 
euglycaemia. Hypoglycaemic levels in the studies were 2.2 mmol'L ' 1 (Draelos et al., 1995), 
2.5 mmol'L"1 (Sommerfield et al., 2003) and 2.65 mmol'L"1 (Evans et al., 2000), whilst 
euglycaemic values were 4.5 mmol'L"1 (Sommerfield et al., 2003), 5.01 mmol'L ’ 1 (Evans et 
al., 2003) and 8.9 mmol'L ' 1 (Draelos et al., 1995) respectively. In each o f the studies 
cognitive performance weakened in the hypoglycaemic state in comparison to euglycaemic 
conditions. Cognitive function was noticed to decline immediately on onset o f 
hypoglycaemia (Evans et al., 2000) with more profound deterioration witnessed in memory 
and immediate processing tasks (Sommerfield et al., 2003).
Gender differences were also noticed with hypoglycaemia negatively effecting males more 
than females (Draelos et al., 1995). One further important observation made by Evans et al. 
(2 0 0 0 ) was that cognitive function can become impaired prior to any symptomatic awareness.
Another factor to consider when discussing cognitive function in hypoglycaemia is the rate as 
to which blood glucose falls. It is established from the examples described previously that 
cognitive function is compromised in a hypoglycaemic state, furthermore cognitive function 
is greater impaired after a rapid decline o f blood glucose. Fanelli et al. (2003) showed that a 
fast fall (0.1 ± 0.003 mmol min"1 L"1) compared to slow fall (0.03 ± 0.001 mmol min ' 1 L"1) in 
blood glucose to a hypoglycaemic level of 2.4 mmol L ' 1 in the postprandial state resulted in 
further deterioration in memory tasks.
In a recent review article (Warren & Frier, 2004), the authors acknowledged that simple tasks 
can still be performed despite moderate hypoglycaemia, however the tasks would take longer 
to complete, thus suggesting a cognitive ‘spare capacity’.
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Table 2.4 Cognitive function studies in hypoglycaem ia
Study Cognitive Functioning 
Tests
Results
(In Hypoglycaemia Compared to 
Baseline or Euglycaemia)
Draelos et al., Neuropsychological Testing: Slower Choice and Simple Reaction
1995 Simple Reaction Time, Choice Times,
Reaction Time, Digit Vigilance Lower Digit Vigilance (Both
(Number of Items and % Errors), Number of Items and % Errors),
Trail-Making Part B, Word Recall, Lower Trail-Making Part B Score,
Serial Digit Learning and Verbal Less Word Recall,
Fluency Lower Serial Digit Learning Score, 
Lower Verbal Fluency.
Evans et al., Four Choice Reaction Time, Stroop Slower Four Choice Reaction Time,
2000 Word and Colour Word Subtests, Slower Stroop Word and Colour
Trail-Making Part B Word Times
Sommerfield et al., Verbal Memory Tests: Lower Scores in immediate AVLT
2003 Auditory Verbal Learning Test and Logical Memory Tests,
(AVLT), Logical Memory Test Lower Score in Benton Visual
Visual Memory Tests: Retention Test,
Visual Reproduction Test, Benton Lower Scores in all delayed verbal
Visual Retention Test and visual memory tests,
Working Memory Tests: Slower times in all working memory
Working Digit Span Test, tests apart from digit span forward
Letter/Number Sequence Test, 
Validation Span Test 
Other Mental Tests:
Trail-Making Part B, Digit Symbol 
Test
test
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2.9.3 Cognitive function in hyperglycaemia
Other literature (Draelos et al., 1995; Gschwend, Ryan, Atchinson, Arslanian & Becker, 
1995; Cox et al., 2005; Gonder-Frederick et al., 2009) has examined the effects of 
hyperglycaemia on cognitive performance compared to euglycaemia. These studies either 
regulated blood glucose by clamp techniques (Draelos et al., 1995; Gschwend; 1995) or 
relied on self-entered blood glucose levels (Cox et al., 2005; Gonder-Frederick et al., 2009). 
Hyperglycaemic blood glucose values were manipulated in the clamp studies to levels o f 20 
mmol'L’ 1 (Gschwend et al., 1995) and 21.1 mmol L ' 1 (Draelos et al., 1995), whilst in studies 
that relied on self-reported data, blood glucose values above 15 mmol L’ 1 (Cox et al., 2005) 
and 22.1 mmol L ' 1 (Gonder-Frederick et al., 2009) were classified as hyperglycaemic.
The findings in the studies were inconsistent as some studies reported no deterioration in 
cognitive performance in hyperglycaemia (Draelos et al., 1995; Gschwend et al., 1995) with 
slowing in cognitive function also being reported (Cox et al., 2005) and observed to be as 
impaired as in a hypoglycaemic condition (Gonder-Frederick et al., 2009). The studies that 
witnessed impaired cognitive function (Cox et al., 2005; Gonder-Frederick et al., 2009) took 
place over a 4 -  6  week long period and relied on self-entering o f blood glucose levels.
Engaging in strenuous exercise has also lead to improvements in cognitive abilities after 
cessation of the activity (Ferris, Williams & Shen, 2007; Hogervorst, Riedel, Jeukendrup & 
Jolles, 1996). These observed improvements in cognitive function have been attributed to the 
individual still being in a highly aroused state that in turn leads to increased activation o f the 
central nervous system (Hogervorst et al., 1996). However, exercising at high intensities as 
previously reported leads to a rise in blood glucose as hepatic production exceeds the rate of 
utilisation (Mitchell et al., 1988). Therefore it may be the combination of both the state of 
arousal and the potentially hyperglycaemic conditions that caused the improvements 
witnessed in these studies.
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Table 2.5 Cognitive function studies in hyperglycaem ia
Study Cognitive Functioning 
Tests
Results
(In Hyperglycaemia Compared to 
Baseline or Euglycaemia)
Cox et al., 
2005
Hand Held Computers which 
presented a number of tasks;
1. Psychomotor Test
2. 10 Mental Subtractions
3 .15 Four-Choice Reaction Time 
Tests
(After tasks user entered blood 
glucose)
Levels o f hyperglycaemia (BG: >15 
mmol L'1) lead to deterioration in all 
tasks
Draelos et al., 
1995
Neuropsychological Testing: 
Simple Reaction Time, Choice 
Reaction Time, Digit Vigilance 
(Number of Items and % Errors), 
Trail-Making Part B, Word Recall, 
Serial Digit Learning and Verbal 
Fluency
Lower Digit Vigilance (Number of 
Items only),
Lower Trail-Making Part B,
Higher Verbal Fluency
Gonder-F rederick 
et al., 2009
Personal Digital Assistant (PDA) Tests 
that presented a mental math test 
followed by a choice reaction time 
(After tasks user entered blood 
glucose)
Math Time was significantly longer 
(BG: > 22 mmol L 1),
Trend for significance (P = 0.08) in 
reaction time (BG: > 22 mmol L'1)
2.9.4 Other influences on cognitive function and recognised methods
Low GI foodstuff as previously discussed (Chapter 2 .5 2 2 )  eaten at breakfast has been 
proven to sustain cognitive performance for a longer period in comparison to high GI 
foodstuff, more specifically in memory and accuracy tasks (Benton et al., 2003; Ingwersen et 
al., 2007). An explanation for this observation could be related to emerging evidence that 
insulin has a key role between mental performance and glucose flux mainly via impaired 
glucose tolerance (Benton et al., 2003). Low GI diets have been shown to produce a lesser
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release o f postprandial insulin (Jenkins et al., 1987), this potentially reduced insulinaemia 
results in a favourable pathway between glucose flow and the brain when the demand occurs 
as opposed to glucose being directed to more insulin sensitive tissues such as the muscles 
(Benton et al., 2003).
An established method of measuring cognitive function is the Stroop colour-word test 
(SCWT), named after the individual who first made the observation in 1935, using congruent 
(shapes o f colour) and incongruent cards (words spelt in a colour that was incorrect i.e. ‘blue’ 
spelt in green letters). Stroop (1935) observed that individuals encountered a disruption and 
delay in naming the colour patches that were shaped to spell an incongruent word. The most 
important finding in these series o f tests is the difference in timing to name incongruent and 
congruent examples (Dyer, 1973) this time difference is commonly referred to as the ‘Stroop 
interference’ or ‘Stroop effect’ (MacKinnon, Geiselman & Woodward, 1985). The Stroop 
colour word was used as part of an array o f tests to assess cognitive function in some of the 
previous discussed research (Evans et al., 2000; Ferris et al., 2007; Hogervorst et al., 1996) 
and is a recognised tool at measuring selective attention, critical in the ability to process task- 
related stimuli (Leung, Skudlarski & Gatenby, 2000). A recent functional magnetic resonance 
imaging (fMRI) study has determined a number of regions are activated in the brain when 
performing the SCWT, these being the anterior cingulate, insula, premotor and inferior 
frontal regions (Leung et al., 2000). Incorporating a selective attention task into a research 
protocol could evaluate whether the choice of carbohydrate has any influence on cognitive 
function prior to and following exercise. Task-relating stimuli may replicate the decisions 
made in real life situations i.e. if following exercise cognitive function is impaired after 
consumption of some carbohydrates, provisions would then need to be made in this clinical 
population to counteract this impairment.
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2.10 Aims and Null Hypotheses
2.10.1 Aims
Within the current literature there is little research that directly investigates exercise 
performance in T1DM and the consequences on glycaemia during and after. Performance 
testing is generally high intensity running which can lead to hyperglycaemia in the T1DM 
population following exercise. The current guidelines in regards to carbohydrate consumption 
and reduction of insulin dosage are more geared towards preventing hypoglycaemia. The 
equally detrimental condition of hyperglycaemia is rarely discussed with very few strategies 
to limit the occurrence.
This study will therefore examine the blood glucose responses after ingestion of high and low 
GI CHO supplementation and whether the lower excursions previously reported (West et al., 
201 lb) limit the incidences of negative hyperglycaemia in T1DM and how this may impact 
upon exercise performance. The main question is whether exercise performance is 
compromised for improved levels of glycaemia. The study will also take into consideration 
cognitive functioning and perceived hunger and fullness ratings after manipulation o f pre­
exercise CHO.
Additionally prior to any main experimental research a series o f pilot studies will take place. 
These studies will:
a) Validate the currently reported GI value for isomaltulose
b) Observe the lactate responses after isomaltulose consumption of differing concentrations
c) Trial the time to exhaustion (TTE) protocol following a bout of submaximal exercise in 
non-TlDM  individuals
d) Investigate whether a learning effect is present following use of the Stroop Colour Word 
Test (SCWT) software
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2.10.2 Null Hypotheses
i. Ingestion o f pre-exercise carbohydrate with different GI values will not influence
glycaemic or metabolic responses at rest or during subsequent exercise
ii. Ingestion o f pre-exercise carbohydrate with different GI values will not influence
substrate utilisation at rest or during submaximal incremental exercise
iii. Ingestion o f pre-exercise carbohydrate with different GI values will not influence high 
intensity exercise performance
iv. Ingestion o f pre-exercise carbohydrate with different GI values will not influence 
cognitive function accuracy or reaction times
v. Ingestion of pre-exercise carbohydrate with different GI values will not influence
perceived feelings o f gut fullness or hunger
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3.0 METHODOLOGY
3.1 Participants and Control
To be considered for recruitment, potential participants had to meet a set of criteria. 
Individuals could be either male or female, aged between 1 8 - 6 0  years old, in moderate 
glycaemic control (assessed by a HbAic score < 11.0% or < 97 mmol'mol"1), engaging in 
physical activity at least twice a week, currently on a basal-bolus insulin regimen for at least 
three months comprising either a combination of insulin glargine (Lantus®) or detemir 
(Levemir®) and insulin aspart (NovoRapid®) or lispro (Humalog®) and no cardiovascular or 
diabetic complications apart from background retinopathy.
Participants were recruited from individuals that had expressed an interest in previous trials 
conducted by the research team, local diabetes clinics and university e-mail advertisements. 
Nine individuals volunteered to take part and completed the preliminary session, of these 
nine, two withdrew through commitment issues, one was excluded due to a level of physical 
inactivity and one individual unfortunately experienced a hypoglycaemic episode outside of 
the laboratory and had to change their insulin regimen and subsequently withdraw from the 
study. Continued advertisement enabled a further two individuals to be recruited for 
participation in this research. Characteristics of these seven participants, two male and five 
female are detailed in the table below.
Table 3.1 Characteristics o f  participants who completed the research study
Participant Characteristics
Age 34 ± 5 years
Height 168.2 ± 2.9 cm
Body Mass 69.8 ± 2.0 kg
BMI 24.9 ± 1.4 kgm ’2
Body Fat 23.8 ± 1.9%
HbAic 76.6 ± 6.5 mmol mol’ 1
V O 2 PEAK 38.7 ± 1 .7  ml kg ' 1 min ' 1
Duration of diabetes 16 ± 5 years
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For the day prior to laboratory attendance, participants were asked to record their dietary 
intake (Appendix 8.3), abstain from unaccustomed physical activity and refrain from drinking 
alcohol. Participants then underwent an overnight fast and were allowed to drink only water, 
avoiding caffeine. Participants administered their long acting insulin, glargine (Lantus®, n =
6 ) or detemir (Levemir®, n =1), as normal either the night before or morning of the 
experimental trial.
3.2 Experimental Apparatus, Calibration and Principles of Operation 
3.2.1 GEM Calibration and Intelligent Quality Management (iOM™)
Prior to experimental sampling, calibration took place using a number of GEM Calibration 
Validation Product (CVP) solutions. Four CVP ampoules (CVP 1, CVP 2, CVP 3 and CVP 
4) were used for this calibration procedure, each ampoule consisted of 2.5ml of a buffered 
bicarbonate solution containing inorganic salts and organic metabolites which were 
equilibrated with concentrations of carbon dioxide and oxygen. Each CVP was composed of 
a different configuration, CVP 1 comprised a solution containing low pH, pC>2 , Na+, K+, 
glucose and lactate values and high pCC>2 and Ca++ values. CVP 2 solution comprised o f high 
pH, pC>2 , Na+, K+, glucose and lactate values and low pCC>2 and Ca++ values. The CVP 3 and 
CVP 4 solutions comprised of low and normal haematocrit values respectively.
Each CVP solution is designated a barcode that corresponded to a specified lot number with a 
pre-determined material value that are recognised by the GEM Premier 3000 (Table 3.2). The 
four barcodes are scanned and then a sample was individually aspirated from each of the 
ampoules, these samples were analysed and cross-referenced against the recognised values 
and either ‘PASSED’ or ‘FAILED’. Once all four samples passed, the Intelligent Quality 
Management (iQM™) feature had been configured and the GEM Premier 3000 was ready for 
use.
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The iQM™ feature is an active control system that ensures that reliable results are produced 
sample upon sample. The iQM™ continually monitors operation of the testing process, 
including sensors, fluidics and electronics and if an error is detected then it will perform and 
document the corrective actions. These checks included:
■ Performing special rinse cycles if micro-clots were detected and subsequently
verifying cartridge function.
■ Disabling a failed sensor permanently if the function could not be recovered
■ Rejecting a cartridge for process stability failure
■ Alerting user upon detection of an interfering substance in a sample
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Table 3.2 GEM CVP values fo r  each variable fo r  the three cartridges used in the 
experimental trials. Values in brackets indicate the acceptance ranges.
Cartridge 1 Cartridge 2 Cartridge 3 Mean CoV
CVP 1
pH (7 .1 6 -7 .2 3 ) 7.16 7.22 7.18 7.19 ±0.02 <0.01%
pC02 (65 -  79 mmHg) 79 66 75 73 ± 4 0.09%
p 0 2 (46 -  64 mmHg) 64 58 56 59 ± 2 0.07%
Na + (1 2 2 -  133 mmol L 1) 129 129 126 128 ± 1 0.01%
K +(2.5 -  3.3 mmolL'1) 2.8 2.8 2.9 2.8 ± 0 .0 0.02%
Ca ++ (1.42 -  1.65 mmol L'1) 1.51 1.47 1.46 1.48 ±0.02 0.02%
Glucose (2.1 -  3.0 mmolL’1) 2.5 2.4 2.7 2.5 ±0.1 0.06%
Lactate (0.7 -  1.1 mmol L'1) 0.9 0.8 0.9 0.9 ± 0 .0 0.07%
CVP 2
pH (7.61 -7 .6 7 ) 7.64 7.65 7.64 7.64 ± 0.00 <0.01%
pC02 ( 2 8 -3 4  mmHg) 31 30 31 31 ± 0 0.02%
p 0 2(133 -  157 mmHg) 138 150 154 147 ± 5 0.06%
Na + (1 5 4 -  165 mmol L 1) 164 162 164 163 ± 1 0.01%
K + (6.2 - 7 .0  mmol L'1) 6.6 6.5 6.5 6.5 ± 0.0 0.01%
C a++(0 .37 -0 .51  m m olL 1) 0.46 0.42 0.42 0.43 ±0.01 0.05%
Glucose (14.8 -  17.5 mmol L'1) 16.5 16.0 16.6 16.4 ± 0 .2 0.02%
Lactate (4.8 -  6.1 mmol L'1) 5.4 5.4 5.7 5.5 ±0.1 0.03%
CVP 3
Haematocrit (21 -  25 %) 23 23 23 23 ± 0 <0.01%
CVP 4
Haematocrit (41 -  48 %) 44 44 44 44 ± 0 <0.01%
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3.2.1.1 Blood Gas, Electrolyte and Metabolite Calculations
For all main experimental testing the GEM Premier 3000 was used to analyse capillary blood 
for the following variables; pH, pCC>2 , pC>2 , Na+, K+, C a^, glucose, lactate and haematocrit. 
These variables were determined by a series of electrochemical sensors located in the self- 
contained disposable GEM Premier 3000 PAK cartridge. These sensors combined with the 
reference electrode and bonded chemically sensitive membranes were fundamental 
components of the chamber body. The sensors with the exception of haematocrit were 
fashioned from layers of polymer films bonded to the substrate. Under each of the sensors 
was a metallic contact that was brought to the surface to form an electrical interface with the 
instrument when sampling occurred.
3.2.1.2 pH and Electrolytes (Na+, K* and Ca ++)
These samples were based on the principle o f ion-selective electrodes and the electrical 
potential established from specific ions and calculated by a simplified version of the Nemst 
equation:
E = E’ + (S x  Log C)
E is the electrode potential, E ’, the standard potential o f the specific membrane, S, the slope 
sensitivity and C, the ion activity. E’ and S are determined from the responses from the 
calibration solutions and the equation solved for the ion activity. In the instance of pH Tog C’ 
is replaced by pH and the equation solved accordingly.
3.2.1.3 Ca++ correction to pH = 7.4
To determine Ca++ the following equation was used with the pH constant value of 7.4:
Ca++ (corrected) = (Ca++(measured) x io ('° 1 7 8 x ( 7  4-pH)))
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3.2.1.4 Carbon Dioxide (pCO? mmHg)
The p C 0 2 sensor relied on a pH selective polymer as a gas permeable outer membrane. The 
pC 0 2 in the internal solution reached equilibrium with the pC 0 2 o f the blood when it came in 
contact with the outer surface of the membrane. The internal solution pH value varies with 
pC 0 2 in agreement with the Henderson-Hasselbalch equation:
pH = pKa + log (H C037 pC 0 2 x a)
pKa is a constant (equilibrium), HCO3 ', the bicarbonate ion concentration and ‘a ’, the 
solubility coefficient of carbon dioxide in water. The pH sensor versus the generated potential 
is related to the logarithm of the pC 0 2 sample content.
3.2.1.5 Oxygen (pQ2 mmHg)
The oxygen sensor consisted of a small platinum electrode primed at a negative potential in 
regards to the reference electrode of the instrument card. The flow of electrical current 
between the ground electrode and platinum surface was proportional to the rate at which 
oxygen molecules diffused to the platinum and was subsequently reduced. This rate o f 
diffusion and reduction was directly proportional to the p 0 2 value and the relationship 
described by the equation:
I = (S x p 0 2) + IZ
I is the electrode current, S, the sensitivity and IZ, the zero current, both the values for S and 
IZ can be calculated from the calibration readings for the sensor. The equation for p 0 2 can be 
solved when I is substituted for the electrode current from the blood sample.
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3.2.1.6 Metabolites (Glucose and Lactate)
The glucose and lactate sensors comprised of a platinum electrode primed at a positive 
potential in regards to the reference electrode o f the instrument card. Determination of the 
metabolites resulted from enzymatic reactions of either glucose or lactate with oxygen in the 
presence of glucose or lactate oxidase and the resulting hydrogen peroxide detected on the 
platinum electrode. The current flow between the ground and platinum electrodes was 
proportional to the rate of diffusion and oxidisation o f the hydrogen peroxide molecules. 
Glucose and lactate concentrations were directly proportional to this rate of diffusion and 
oxidisation and the relationship describes as:
I = (S x metabolite) + IZ
I is the electrode current, S, the sensitivity and IZ, the zero current, both the values for S and 
IZ can be obtained from the calibration readings for the sensor. The metabolite concentrations 
can be calculated when I is substituted for the electrode current from the blood sample.
3.2.1.7 Haematocrit (Hct)
An electrical conductivity technique was employed to determine blood haematocrit. The 
technique was based on the rule that blood plasma is more conductive than blood cells as a 
result of the high resistance of cell membranes. The resistivity of blood determined by an 
alternating current within the sensor, will therefore increase as the concentration of cells 
increases and this relationship shown by the Maxwell-Fricke equation:
r = Rp x (1 + Hct/100) / (1 -  Hct/100)
r is the blood resistivity, Rp, a constant based on plasma resistivity and Hct, haematocrit.
45
3.2.2 YSI 2300 Stat Plus (YSI Incorporated, Yellow Springs, Ohio)
3.2.2.1 Linearity Procedure
The YSI 2300 Stat Plus (YSI Incorporated, Yellow Springs, Ohio) was used in two o f the 
four pilot trials; (Chapter 3.3.2.1 and Chapter 3.3.2.3) to analyse blood glucose and lactate 
concentrations. Each morning prior to experimental sampling, the instrument was tested for 
linearity and membrane structural integrity using a number o f pre-determined standard 
solutions.
The linearity procedure involved five glucose and five lactate samples of different 
concentrations to determine the instrument was working correctly. D-Glucose 25.0 mmol L ' 1 
standard (YSI 2369) was used as the first sample, the four remaining glucose samples were 
mixed with distilled water to create 12.5, 6.25, 3.125 and 1.56 mmol'L"1. For the five lactate 
samples, L-Lactate 15.0 mmol I / 1 standard (YSI 2328) was used first, with the four other 
concentrations being 7.5, 3.75, 1.875 and 0.938 mmol'L"1.
Structural integrity was measured by a 25pl sample of Potassium Ferrocyanide (FCN, YSI 
2363), FCN readings above 0.3 mmol L"1 (glucose) or above 0.6 mmolL ' 1 (lactate) would 
highlight potential membrane structural problems.
Once the linearity procedure was completed and results were within accepted levels, the YSI 
2300 Stat Plus was ready for experimental use, every 30 minutes the instrument would 
automatically calibrate to ensure there were no differences in the baseline currents.
3.2.2.2 Blood Glucose and Lactate Calculations
Blood substrate concentrations were determined by sensor and probe technology that 
incorporated patented immobilised membranes. Each probe located in a buffer filled sample 
chamber was fitted with a three layer membrane that contained an immobilised membrane as 
the middle section. When a sample was injected into the chamber, some of the substrate 
diffused through the membrane. On contact with this immobilised oxidase enzyme, it was 
rapidly oxidised to produce hydrogen peroxide (H2O2). The glucose reaction is displayed
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below. The produced H2 O2 was then oxidised at the platinum anode within the chamber and 
subsequently, electrons were produced (Reaction 2). Equilibrium between H2 O2 production 
and the rate the H2O2 leaves the enzyme layer ensues. The rate of electron flow was linearly 
proportional to this equilibrium and in turn, proportional to the concentration of substrate.
REACTION 1 (glucose): P-D-glucose + O2 ^  Glucono-8 -lactone + H2 O2
GOx
REACTION 2: H2 0 2  ► 2H+ + 0 2 + 2e‘
Pt anode
3.2.3 Portable Gas Analyser (Metamax 3b, Cortex Biophysik, Germany)
3.2.3.1 Calibration of gas analyser
On each morning of the experimental trials and before use in the preliminary trials, the 
portable gas analyser (Metamax 3b, Cortex Biophysik, Germany) was calibrated. The unit 
was calibrated in each instance for air pressure, gas concentrations and volume.
Air Pressure
To calibrate for air pressure, the day to day pressure was input (mbar).
Gas Concentrations
To calibrate gas concentrations for oxygen (O2) and carbon dioxide (CO2 ), a two-point 
calibration took place. The first gas sample used was ambient air (20.93% O2 , 0.03% CO2), 
which validated the upper limits for O2 and lower limits for CO2 . The second gas sample 
validated lower limits of O2 and upper limits for CO2 , and was unique to the concentration in 
the gas bottles in the laboratory (15.2% O2 , 4.88% CO2) for this reason the values had to be 
manually entered into the computer software (Metasoft, Cortex Biophysik, Germany)
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Volume
To calibrate volume, a known volume had to be selected and validated, for this procedure a 3 
litre calibration syringe (Hans Rudolph Incorporated, USA) was used. Five valid inspiration 
and expiration strokes were needed for calibration, once accepted calibration o f volume had 
been completed.
3.3 Procedures
3.3.1 Measurement Procedures
3.3.1.1 Capillary Blood Sampling
Blood samples (170 pi) were obtained via capillary puncture from the fingertip for 
subsequent analysis using either the YSI 2300 Stat Plus (YSI Incorporated, Yellow Springs, 
Ohio)(Chapter 3.3.2.1 and Chapter 3.3.2.3) or GEM Premier 3000 (Instrumentation 
Laboratories, UK)(Chapter 3.3.2.2 and Chapter 3.3.3). Once the area for puncture had been 
allocated, the site was cleaned using a 70% isopropyl alcohol swab (Universal Hospital 
Supplies Limited, UK) and wiped with a tissue. The side of the fingertip was then punctured 
with a lancing device (Accu-Chek Safe T-Pro Plus, Roche, UK) and the first drop of blood 
cleaned away with a tissue. The finger was then massaged and blood collected, -75  pi was 
collected in sodium heparinised capillary tubes (Hawksley and Sons, Sussex, UK) for YSI 
samples and ~ 170 pi collected in plastic lithium heparinised capillary tubes (Instrumentation 
Laboratories, UK) for GEM samples. 25 pi samples were presented to the YSI for glucose 
and lactate analysis and a minimum 145 pi sample was aspirated by the GEM for blood gas, 
electrolyte and metabolite analysis.
3.3.1.2 Determination of body composition
Percentage body fat of participants in the main experimental trials was calculated with the 
bio-impedance analyser (BIA, Bodystat Quadscan 4000, Bodystat Limited, UK). Individuals 
were required to remove all metallic objects and rest in a supine position away from any 
metallic contact.
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The BIA contains four electrodes, two positive and two negative, two electrodes were placed 
on the wrist the positive electrode placed proximal to the third metacarpophalangeal joint and 
the negative electrode positioned on the wrist next to the ulnar head. The remaining two 
electrodes were placed on the ankle the positive electrode positioned proximal to the third 
metatarsophalangeal joint and the negative electrode between the medial and lateral malleoli. 
A number of small currents (5, 50, 100 and 200 kHz) are passed through the electrodes, the 
BIA works on the basic principle that lean muscle retains water and adipose tissue does not. 
Water is a very good conductor of electricity and therefore the resistance of the current is 
measured which would be the adipose content.
Participant characteristics such as age, height, body mass, waist and hip circumferences are 
all input into the device. Using these variables the BIA calculates and displays a percentage 
body fat value on the screen.
3.3.1.3 HbAir Analysis
On one of the two experimental mornings, a 4 ml venous blood sample was obtained from 
each of the participants and collected in a Na+ EDTA tube. This sample was then sent to a 
local hospital and analysed for HbAic using the method of high performance liquid 
chromatography (HPLC) with cation exchange. Once analysis was complete the results were 
posted back to the research team.
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3.3.2 Pilot Studies
As stated in the aims (Chapter 2.10.1) a series of pilot studies were to take place prior to any 
research in the T1DM participants taking place. The next few pages documents these pilot 
studies and their findings and how these findings contributed to the final methodology 
adopted for the research protocol.
3.3.2.1 Pilot Study 1: Determination of glvcaemic index (GI) of isomaltulose and 
metabolic responses following ingestion
As previously stated (Chapter 2.5.2.3), isomaltulose (ISO, Palatinose®, Beneo Group, 
Germany) has been reported to have a very low GI of 32 (Atkinson et al., 2008). To verify 
this low GI value, the methodology documented by Brouns et al. (2005) was adhered to. 
Brouns et al. (2005) recommend that blood samples should be taken at seven determined time 
points, at least ten individuals participate in the study, the test food is trialled on two 
occasions, 50 g of carbohydrate is provided within the test and reference food and that the 
reference food is glucose or white bread. In addition, low GI diets as discussed beforehand 
(Chapter 2.5.2.2) have been shown to be beneficial to people with type 1 diabetes in 
controlling levels of blood glucose (Nansel et al., 2008) and therefore further research in 
novel CHOs such as ISO warranted investigation. Therefore, the aim of this study was to 
determine and verify the reported GI value of ISO using a recommended reference food 
(DEX, Glucose Powder).
Ten participants (23 ± 1 year; BMI, 25.0 ± 1 . 1  kgm ' ) were recruited, advised of project 
details (Appendix 8.1), provided informed consent (Appendix 8.1) and completed this study. 
Participants attended the laboratory on four mornings at the same time after an overnight fast 
and abstaining from unaccustomed physical activity for 24 hours. On arrival, stature 
(Stadiometer, Holtain Limited, UK) and body mass (Seca 770 Digital Scales, Seca Limited, 
UK) were recorded before participants were asked to remain seated prior to a resting blood 
sample being taken. Blood samples were obtained via capillary puncture (Chapter 3.3.1.1) 
and taken at specified time points throughout a 2 hour rest period. The first of these samples 
was taken at rest and analysed immediately (YSI 2300 Stat Plus, YSI Incorporated, Yellow 
Springs, Ohio) for levels of blood glucose and lactate.
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Once the resting sample had been obtained and analysed, participants were provided with 
50 g o f either the test food, ISO or reference food, dextrose (glucose powder) (DEX, 
Thornton & Ross, UK) dissolved in 250 ml distilled water, 20% solution, on two occasions 
each in a randomised, counterbalanced fashion. Participants were instructed to consume the 
solution within 5-minutes and to remain at rest throughout the 2-hour period. Further 
capillary blood samples were taken 15, 30, 45, 60, 90 and 120-minutes following ingestion of 
the carbohydrate and again analysed immediately for blood glucose (BG) and lactate (YSI 
2300 Stat Plus).
Peak BG values in DEX (7.63 ± 0.20 mmol L '1) were significantly higher than the peak 
response in ISO (5.89 ± 0.11 mmol'L'1, P < 0.001), however there were no differences 
between lowest BG values between conditions (DEX; 4.17 ± 0.21 vs. ISO; 4.46 ±0 . 11  
mmol'L'1, P > 0.05). The BG incremental area under the curve (IAUC, Equation D) for DEX 
(166.78 ± 18.36 mmol'min'L"1) was significantly higher (P < 0.001) than ISO (89.19 ± 8.42 
m m olm inL '1), from these values the GI o f ISO was calculated to be 53.
Lactate values over the 2 hour resting period were found to be significantly higher after 
ingestion o f ISO when compared to DEX, (P < 0.05), this fact was translated in the peak 
lactate levels where ISO had a significantly higher value than DEX, (1.43 ± 0.07 vs. 0.92 ± 
0.06 mmol L '1, P <  0.001).
The different GI o f 53 calculated in this study could be attributed to a number of factors. In 
the reported data (Atkinson et al., 2008) only 50 g of the product was supplied as the test 
food, which differed in this study as 50 g of available CHO was given both as the test and 
reference foods. 50 g o f available CHO is recommended by Brouns et al. (2005) and this may 
lead to more than 50 g of the test food being supplied if  the food does not have a 
carbohydrate content of 100 g/100 g product, (i.e. if  the test food contains 94.6 g CHO per 
100 g of the product then participants would be provided with a 52.9 g serving so that 50 g of 
CHO is available). It has been further documented that up to ten reference foods have been 
provided in the compilation of earlier GI lists (Foster-Powell et al., 2002), however glucose 
and white bread are deemed the recommended reference foodstuffs (Brouns et al., 2005). 
With no definitive test portions or reference foods, it is likely to observe discrepancies in GI 
values between studies.
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Figure 3.1 Blood glucose (A) and blood lactate (B) responses following ingestion o f  CHO. 
(*) denotes significant difference between conditions (P < 0.05).
Blood lactate levels were elevated in ISO throughout the sam ple points due to the nature o f  
m etabolism  where ISO is broken down into glucose and fructose. This fructose bypasses the 
phosphofructokinase regulatory point in glycolysis and results in an increased flux through 
the glycolytic pathw ay that in turn leads to a build-up and release o f  lactate (K aye et al., 
1958; Sahebjam i & Scalettar 1971).
ISO was found to have a higher GI than previously reported, 53 as opposed to 32, how ever 
this score is still classified as low (A tkinson et al., 2008). This low GI value resulted in fewer 
undulations over the 2 hours when com pared to DEX and also in the lower peak BG value. 
The lactate values at rest are o f  interest as these higher values in ISO m ay have a potentially 
detrim ental effect on perform ance.
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3.3.2.2 Pilot Study 2: Blood lactate and glucose responses after ingestion of isomaltulose 
at different concentrations
Taking into account the lactate findings after completion of Pilot Study 1 (Chapter 3.3.2.1), it 
was decided to investigate whether there was a conditional effect in regards to blood lactate 
production with differing concentrations of isomaltulose. Lactate accumulation can prove 
detrimental to exercise performance and elevated levels prior to performance testing could 
hinder the effect of the carbohydrate supplementation. Alongside investigating the potential 
for a conditional effect of lactate, this study would also allow for drink concentration to be 
examined as mentioned previously (Chapter 2.5.2.1) the literature is inconsistent as to which 
is the optimum concentration to provide with values suggested ranging from 6 % (Riddell & 
Perkins, 2006) up to 10% (Perrone et al., 2005; West et al., 201 la; West et al., 201 lb). Drink 
concentration is also of importance in regards to glucose provision with individuals more 
susceptible to hypoglycaemia after consumption of lower concentration fluids (Perrone et al., 
2005). The aim of this study is therefore to investigate the lactate and glucose responses 
following drink concentrations of 5 and 10% isomaltulose and to examine whether a dose 
response is present.
Five males (25 ± 2 years, BMI, 26.1 ±1 .3  kg m'2) participated and completed this pilot trial, 
attending the laboratory twice in the morning after an overnight fast. On arrival stature and 
body mass were recorded and participants were asked to remain at rest prior to a capillary 
blood sampled being obtained (Chapter 3.3.1.1). Participants were then provided in a 
randomised fashion either 5% (12.5 g ISO) or 10% (25 g ISO) in a 250 ml distilled water 
solution which was consumed within five minutes. Further capillary blood samples were 
obtained at 30, 60, 90 and 120 minutes following consumption of the test drink. All blood 
samples were analysed immediately for blood glucose and lactate (GEM Premier 3000, 
Instrumentation Laboratories, UK).
Peak lactate values were significantly higher in the 10% condition compared to the 5% 
condition (10% solution; 2.3 ± 0 . 1  vs. 5% solution; 1.9 ± 0.2 mmol L '1, P < 0.05). This 
observation is reflected in the relative peak values, where a two-fold increase is shown ( 1 0 % 
solution; 1.2 ± 0.3 vs. 5% solution; 0.5 ± 0.2 mmol L '1, P = 0.05). Over the time points the 
only significance difference between conditions was apparent at 30 minutes following
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ingestion when relative lactate responses are measured, (10% solution; 0.7 ± 0.2 vs. 5% 
solution; 0.4 ± 0.2 mmol L '1, P < 0.05).
Absolute glucose values were significantly higher in the 10% condition when compared to 
the 5% condition (10% solution; 6.7 ± 0.4 vs. 5% solution; 5.8 ± 0.2 mmolL"1, P < 0.05). 
Relative peak values were also significantly higher between conditions (10% solution; 1.4 ± 
0.4 vs. 5% solution; 0.5 ± 0.2 mmolL"1, P < 0.05) which were the values that corresponded to 
the 30-minute time point.
Resting lactate and glucose levels were similar between conditions (Lactate: 10% solution;
1.1 ± 0.3 vs. 5% solution; 1.3 ± 0.3, Glucose: 10% solution; 5.4 ± 0.2 vs. 5% solution; 5.2 ± 
0.1 mmol L"1, P > 0.05).
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Figure 3.2. Relative blood lactate (A) and blood glucose (B) responses following ingestion o f  
5% and 10% ISO solutions. (*) denotes values significantly higher (P < 0.05).
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These findings show that a dose response relationship is present in isomaltulose. However, 
with a 2 -hour resting period to allow for digestion of carbohydrate, the lactate responses in 
the 10% solution are comparable with the 5% solution whilst preserving higher levels of 
blood glucose.
3.3.2.3 Pilot Study 3: Trial of potential methods in non T1DM individuals
Exercise performance is one of the most important components of research in sport (Currell 
& Jeukendrup, 2008). The reliability o f time to exhaustion (TTE) protocols has recently been 
questioned (Laursen et al., 2007) and defended (Hopkins et al., 2001) due to the high 
variation in the results obtained. However, with the potential for carbohydrate sparing in 
some research trials (Febbraio et al., 2000; Thomas et al., 1991: Wee et al., 2005; Wu et al., 
2003) use of a TTE assessment to explore this possibility may be a preferential method in the 
future research. Therefore, the aim of this study was to investigate the reliability and 
suitability of a TTE protocol instead of a time trial (TT) assessment for adoption in the future 
research. The participants would also trial the Stroop Colour Word Test (SCWT) software 
and also the gut fullness and hunger scales , providing feedback on their usability.
Eight individuals (23 ± 1 year, BMI, 23.8 ± 1.0 kgm '2, Peak VO2 , 51.3 ± 0.4 m lkg^ m in'1) 
were recruited, notified of project details (Appendix 8.1) and provided both informed consent 
(Appendix 8.1) and medical history (Appendix 8.1) before completing this trial. Each 
participant attended the laboratory on three occasions, primarily for a preliminary session to
quantify VO2 peak- This value was determined by a 3 -minute stage continuous running 
treadmill (ERGO ELG55, Woodway GmbH, Germany) protocol, beginning at 8  km h ' 1 and 
increasing by 1 km h’ 1 until volitional exhaustion. Expired air samples were collected in 
Douglas bags in the last minute of each stage and analysed for gas concentrations (Hi-Tech 
GIR250 Dual Gas Analyser, Luton, UK) and volume (Harvard Dry Gas Meter, Kent, UK).
Participants attended for two further visits after an overnight fast, on arrival to the laboratory 
stature (Stadiometer, Holtain Limited, UK) and body mass (Seca 770 Digital Scales, Seca 
Limited, UK) were measured and individuals were then seated. Participants then completed 
the online Stroop colour word test (SCWT) and indicated their perceived feelings o f hunger 
and gut fullness (Appendix 8.4) prior to a resting blood sample being taken via capillary
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puncture (Chapter 3.3.1.1). Individuals were then provided in a randomised counter balanced 
fashion either 0.6 g kg ' 1 body mass o f dextrose (DEX, Thornton & Ross, UK) or waxy barley 
starch (WBS, Vitargo®, Swecarb AB, Sweden), 9% solution, which they were required to 
drink within five minutes. Further capillary blood samples were taken at 30, 60 and 120 
minutes after carbohydrate consumption, with the SCWT and perceived feelings of hunger 
and gut fullness completed again at 1 1 0  minutes.
At 120 minutes, participants started a discontinuous incremental exercise protocol beginning 
at 6  km h"1 and increasing by 1 km h"1 every 5 minute stage. Participants were required to run 
for four minutes o f each five minute stage, in the non-exercising minute, participants would 
place one foot either side of the treadmill belt and a capillary blood sample obtained, this
procedure was continued until 85% of peak VO2 was reached. After a 90 s rest period, 
individuals then performed a TTE trial at this 85% intensity, participants were blinded from 
the duration of the TTE trial.
On cessation of exercise a capillary blood sample was taken, with a further blood sample 
obtained 15 minutes into the recovery period. The SCWT test and gut fullness and hunger 
ratings were recorded for a final time after the recovery blood sample had been obtained. All 
capillary samples were analysed immediately for blood glucose (BG) and lactate values (YSI 
2300, Yellow Springs, Ohio). Expired air samples were collected in the last exercising minute 
of each stage, and analysed for gas concentrations (Hi-Tech GIR250, Luton, UK) and volume 
(Harvard, Kent, UK), no expired air samples were collected during the TTE trial. Substrate 
utilisation was calculated using principles o f indirect calorimetry derived by Jeukendrup and 
Wallis (2005).
As stated in the aims, the purpose of this study was not to examine metabolic or substrate 
responses to carbohydrate ingestion and exercise per se, the primary focus being to evaluate 
whether the TTE trial proposed would allow a potential subtle performance effect to be 
discovered. TTE between conditions were similar, (DEX: 934 ± 140 vs. WBS: 1058 ± 191 s, 
P = 0.61) however the large values for standard error and co-efficient of variation (CoV) were 
both causes for concern.
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Figure 3.3. TTE results following ingestion o f  CHO. (A) illustrates individual participant 
results and improvement after consumption o f  CHO. (B) illustrates average participan t TTE 
between conditions.
W ith these findings from this pilot study, it was decided that for the m ain experim ental trials, 
that a time trial (TT) would be used as opposed to a TTE perform ance test. The higher CoV 
values have been previously docum ented (Jeukendrup et al., 1996) to suggest that adoption o f 
the TTE protocol has low reliability, this was one o f  the main reasons for the decision taken. 
It was also proposed that to ensure all participants were exercising sim ilar in the subm axim al 
bout that exercise intensities would be incorporated in the m ethods opposed to set velocities. 
W ith all participants exercising at relative intensities the w orkload com pleted in the 
subm axim al protocol would be com parable betw een individuals. A set w orkload followed by 
a time trial protocol is recognised as a validated and reliable technique to m easure 
perform ance (Jeukendrup et al., 1996). Participants reported that they had no issues with 
either the SCW T software or the gut fullness and hunger scales.
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3.3.2.4 Pilot Study 4: Potential learning effect of Stroop colour word test
Ingestion of breakfast alone (Wesnes, Pincock, Richardson, Helm & Hails, 2003), 
carbohydrate supplementation of varying glycaemic indexes (Benton et al., 2003; Ingwersen 
et al., 2007) and exercise (Ferris et al., 2007; Hogervorst et al., 1996) are all independent 
factors that influence cognitive function. To eliminate the chance that any potential 
differences found in the research were attributable to familiarisation (learning effect) a small 
pilot trial took place. The aim of this study was to examine whether participants improved 
their scores and reaction times following continued use of the Stroop colour word test 
(SCWT) software.
The online package (http://cat.xula.edu/thinker/flash/stroop.swf) shows a series of twenty 
words, either blue, black, yellow, green or red, and ten of these words are written in the 
corresponding colour that they spell (congruent) or ten written in one of the remaining four 
colours (incongruent). Users have to click the colour that is shown, not necessarily the word 
displayed, the package displays the scores and average reaction time (seconds) for both 
congruent and incongruent sections.
Five individuals (23 ± 1 year) volunteered for this study and were required to attend the 
laboratory on one morning after completion of an overnight fast. Participants completed the 
SCWT on three occasions, at 0, 110 and 180 minutes, these time points being representative 
of the time points in the main study. Participants were allowed to drink water ad libitum, 
however they were instructed to remain at rest and refrain from eating.
Congruent scores over time were similar (0 min; 10 ± 0.0, 110 min; 10 ± 0.0, 180 min; 9.8 ± 
0.2, P > 0.05), however reaction times decreased through use (0 min; 1.38 ± 0.10 s, 110 min; 
1 . 1 2  ± 0.03 s, 180 min; 1.09 ± 0.06 s), but this increased response was not significantly 
different (P > 0.05). With regards to incongruent reaction times, when compared against 
baseline the subsequent time points were significantly different ( 0  min; 1.62 ± 0.06 s vs. 1 1 0  
min; 1.17 ± 0.05 s, P < 0.05) and (0 min; 1.62 ± 0.06 s vs. 180 min; 1.15 ± 0.06 s, P < 0.05), 
again the correct scores were similar across conditions (0 min; 9.6 ± 0.2, 110 min; 10 ± 0.0, 
180 min; 10 ± 0.0, P > 0.05).
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These findings present that regardless of supplementation, reaction times increase through 
usage of the online SCWT software. Using this information it was decided that within the 
familiarisation session, participants would be exposed to the SCWT software prior to the 
main experimental trials. Thus, removing the potential learning effect and allowing subtle 
between condition differences (if any) to be located.
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3.3.3 Experimental Trials
3.3.3.1 Familiarisation Session and Protocol for determination of VO? pfak and H R p f a k
Prior to the main experimental trials, each participant attended the laboratory either once or 
twice for a familiarisation session which incorporated preliminary testing. The main purpose
o f this testing was primarily to determine individual peak values o f oxygen uptake (VO2 peak) 
and heart rate (H R peak) and to provide the opportunity for each participant to adapt to both 
the laboratory surroundings and the experimental equipment. In addition to the preliminary 
protocol, participants completed three five minute bouts on the non-motorised treadmill 
(Curve, Woodway GmbH, Germany) and completed the online SCWT three to five times. All 
participants were notified of research details (Appendix 8.2), completed both informed 
consent (Appendix 8.2) and provided full medical history (Appendix 8.2) before engaging in 
any exercise pertaining to this research study.
To determine peak rates of oxygen uptake and heart rate each of the participants completed a 
running protocol on a motorised treadmill (ERGO ELG55, Woodway GmbH, Germany). On 
arrival to the laboratory stature (Stadiometer, Holtain Limited, UK) and body mass (Seca 770 
Digital Scales, Seca Limited, UK) were recorded. Individuals were all required to wear a 
heart rate monitor (RS400, Polar Electro, Oy, Finland) positioned under their clothing just 
below the xiphoid process and also the portable breath-by-breath gas analyser (Metamax 3b, 
Cortex Biophysik, Germany).
For this preliminary session, participants were asked to prepare in the fashion that they would 
for an exercise session, prior to exercise all participants were required to check their blood 
glucose with their own meters. If values were deemed too low, < 8  mmol L ' 1 participants 
were supplemented with 2 0  g of dextrose mixed with 2 0 0  ml distilled water.
After monitoring blood glucose, participants were asked to perform a warm up on the 
treadmill, beginning at a low intensity (~5 km h '1) to become familiar with the treadmill and 
wearing the portable gas analyser, the speed of the treadmill was manipulated periodically 
and heart rate was continually assessed. From this brief warm-up and assessment of heart rate
60
responses, the initial velocity for the protocol was determined, six participants started at 8  
km h ' 1 and the remaining individual began the protocol at 6  km h '1.
The running protocol that was used to determine VO2 peak and HR peak was continuous in 
nature and consisted of 3-minute stages that increased by 1 km h '1, participants received 
verbal encouragement towards the latter end of the protocol and were required to continue 
until volitional exhaustion. On completion of the protocol, the portable gas analyser was 
removed and participants engaged in an active cool down walking at a comfortable intensity.
VO 2 peak and HR peak values were taken from the last completed full minute of exercise. HR 
and breath-by-breath data was continuously collected and recorded via radio-telemetry 
software (Metasoft, Cortex Biophysik, Germany).
After sufficient recovery participants were then given the opportunity to familiarise 
themselves with the online SCWT software. The software included a screen that provided 
detailed instructions to how the program works, all participants read these instructions and 
were given the opportunity to ask any questions or queries that they may have had. Once any 
queries were answered and resolved, participants completed the task between three to five 
times to a level that they were comfortable with the software.
Participants were then given the option to either partake in a series of exercise bouts on the 
non-motorised treadmill after completion of the SCWT or to make arrangements and return 
to the laboratory at another convenient time. The purpose of these exercise bouts on the non- 
motorised treadmill were so that both the individual and ourselves were confident that they 
could control the belt o f the treadmill, allowing for either acceleration or deceleration to 
occur. Participants were firstly given around 7 - 1 0  minutes of free running on the treadmill, 
before completing three 5 minute bouts at a speed that could be easily controlled. At the end 
of the 5 minutes, the distance completed was recorded. The second and third distances were 
compared together for treadmill competency, over these final two exercise bouts participants 
completed 0.53 ± 0.04 km, CoV = 2.23 ± 0.55%, with individual competency shown in Table 
3.3.
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Table 3.3 The familiarisation of each individual and their competency in using the non-motorised 
treadmill over 3 x 5  min runs
Run 2 (km) Run 3 (km) Average (km) CoV
Participant A 0.45 0.47 0.46 3%
Participant B 0.52 0.54 0.53 3%
Participant C 0.47 0.49 0.48 3%
Participant D 0.73 0.74 0.74 1 %
Participant E 0.64 0 . 6 8 0 . 6 6 4%
Participant F 0.46 0.46 0.46 0 %
Participant G 0.41 0.42 0.42 2 %
3.3.3.2 Main Experimental Trial
Participants attended the laboratory on two occasions, separated by at least 48-hours after 
completion of an overnight fast ( 1 0  -  14 hours) and abstaining from unaccustomed physical 
activity for the previous 24 hours.
3.3.3.3 Rest Period
On arrival to the laboratory, participants were asked to change into the clothing that they 
would be exercising in and remove their footwear before body mass (BM) was recorded 
(Seca 770 Digital Scales, Seca, UK) subsequently followed by stature being noted 
(Stadiometer, Holtain Limited, UK). Participants were then asked to comment about their 
perceived feelings of gut fullness and hunger (Appendix 8.4) prior to completing the SCWT. 
Once these resting scores for the gut fullness and hunger and the SCWT had been recorded, a 
resting blood sample was obtained via capillary puncture (Chapter 3.3.1.1) and immediately 
analysed (GEM Premier 3000, Instrumentation Laboratories, UK). Participants were then 
made aware of the carbohydrate amount that would be provided and reduced their normal 
rapid-acting insulin (Aspart ‘NovoRapid®’, n =5) or (Lispro ‘Humalog®’, n = 2) dose by 
50% (2.7 ± 0.3 Units), which was administered in the leg, arm or abdomen by individual 
preference.
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Participants were then supplied with 0.6 g kg ' 1 BM of either isomaltulose (ISO, Palatinose®, 
Beneo Group, Germany, 41.82 ± 1.26 g) or dextrose (DEX, MyProtein.com, UK, 41.89 ± 
1.15 g) mixed to a 10% solution in a 1 litre opaque sports bottle. Participants were given 5 
minutes to consume the solution once they had started to drink and were advised of this 
beforehand.
Individuals were instructed to remain at rest for a 2-hour period where they either sat or lay 
on a bed. Further capillary blood samples were obtained 30, 60, 90 and 120 minutes after 
carbohydrate consumption and these were again analysed immediately (GEM Premier 3000). 
Between 100 -  115 minutes participants wore the portable gas analyser (Metamax 3b, Cortex 
Biophysik, Germany) alongside a heart rate monitor (Polar RS400, Electro Oy, Kempele, 
Finland) and resting expired air concentrations and heart rate were recorded via radio - 
telemetry software (Metasoft, Cortex Biophysik, Germany). After the rest samples, 
participants again completed the SCWT and were asked about their perceived feelings of gut 
fullness and hunger.
On one of the two mornings a venous blood sample was collected for analysis of HbAic 
(Chapter 3.3.1.3) and body composition was calculated (Bio-impedance analyser (BIA), 
Bodystat Quadscan 4000, Bodystat Ltd, UK, Chapter 3.3.1.2).
3.3.3.4 Submaximal Exercise
Two hours following carbohydrate ingestion, participants (still wearing the portable gas 
analyser (Metamax 3b) and heart rate monitor (Polar RS400)) mounted a large motorised 
treadmill (ERGO ELG55, Woodway GmbH, Germany) to perform a discontinuous 
incremental 5.5-minute stage exercise bout comprised of 5 bouts o f 4-min walking or running 
interspersed with 90 s rest. The incremental running velocities were a percentage of the final 
speed reached in the preliminary maximal exercise protocol. The increments performed were 
31 ± 1% (4.3 ± 0.2 km h '1), 41 ± 2% (5.4 ± 0.3 km h'1), 53 ± 2% (6.4 ± 0.3 km h'1), 69 ± 3% 
(7.5 ± 0.4 km h"1) and 80 ± 2% (8 . 6  ± 0.5 km h'1) of maximal oxygen uptake.
Participants ran for the first 4-minutes o f each stage and then placed one foot each side of the 
treadmill belt so that a capillary blood sample could be obtained and analysed immediately 
(GEM Premier 3000). Once the 90 s stationary period had elapsed, participants eased
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themselves back on to the treadmill belt and carried on running at the next increment speed. 
Once the running component of the final stage was completed, the treadmill belt was stopped 
and a 5-minute rest period began. During this rest period participants drank water ad libitum.
3.3.3.5 Performance Running and Recovery
After 5 minutes, participants completed a 3 minute warm-up period on the non-motorised 
treadmill (Curve, Woodway GmbH, Germany), which when completed participants placed 
one foot either side of the treadmill belt and a pre-performance capillary blood sample was 
obtained and analysed (GEM Premier 3000). The non-motorised treadmill was then 
programmed for 1 0  minute duration and participants were blinded from the speed that they 
were performing exercise at. Video recording (Nikon D5000, Nikon, UK) o f the exercise 
bout was synchronised with the start of the performance test. Distance was noted every 2.5 
minutes and participants received strong vocal encouragement throughout. In the final twenty 
seconds of exercise, participants were asked their perceived ratings o f physical exertion 
(Borg, 1973). On cessation of exercise, the breath-by-breath and heart rate recording was 
stopped, the portable gas analyser (Metamax 3b) removed and a post-performance capillary 
blood sample taken.
Participants then remained at rest for the following 15 minutes, and were allowed to drink 
water ad libitum. A final capillary blood sample was obtained and analysed (GEM Premier 
3000), alongside a 0.3 pi blood sample which was analysed with a glucose meter (Freestyle 
Lite, Abbott Diabetes Care, UK). The SCWT was completed for the final time together with 
the perceived feelings of gut fullness and hunger.
Participants were then free to leave the laboratory, provided with a glucose meter (Freestyle 
Lite, Abbott Diabetes Care, UK) and asked to self-record their blood glucose values 3 and 6  
hours after leaving (Appendix 8.3) alongside their dietary intake and insulin doses 
administered (Appendix 8.3).
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3.4 Calculations and Data Analysis
3.4.1 Substrate Utilisation and Energy Expenditure
Substrate utilisation was measured at rest, from the last minute o f each submaximal stage and 
quarterly throughout the performance bout and calculated using the principles of indirect 
calorimetry via the methods proposed by Jeukendrup and Wallis, (2005).
Carbohydrate oxidation (g m in'1) (Equation A)
= 4.344 x VCO2 -  3.061 x VO2 (Low intensity exercise, 40 -  50% VC>2 m ax)
= 4.210 x VCO2 -  2.962 x VO2 (Moderate to high intensity exercise, 50 -  75% VO2 m a x)
Fat oxidation (gm in '1) (Equation B)
= 1.695 x VO2 -  1.701 x VCO2 (All exercise intensities)
Energy expenditure was calculated from the carbohydrate and fat oxidation rates via the 
methods o f Frayn (1983).
Energy Expenditure (kJm in'1) (Equation C)
= 15.6 x Carbohydrate oxidation (gm in '1) + 39 x Fat Oxidation (gm in '1)
3.4.2 Blood Glucose
Incremental area under the curve (IAUC) was calculated following the equations outlined by 
Brouns et al. (2005) (Equation D)
For the first time point, if  BGi> BGo, then Si = (BGi -  BGq) x (Ti -  To) / 2, otherwise Si = 0.
65
For the remaining time points using BGi and BG2 as an example the following equations 
were performed.
If both BGi and BG2> BG0, then S2 = (BGi/2 + BG2/2) x T
If  BGi> BG0  and BG2< BG0, then S2 = (BGi2/(BGi -  BG2)) x T/2
If BG|< BG0  and BG2> BG0, then S2 = (BG22/(BG2 -  BG,)) x T/2 
If both BGi and BG2< BGo, then S2 = 0.
BGo is the blood glucose resting or first concentration, B G i... are relative blood glucose 
values, T is equal to time and S represents segment number.
All segments would be totalled together to calculate IAUC.
3.4.3 Data Analysis
Statistical analysis was carried out using SPSS Version 16 software (SPSS Incorporated, 
Chicago, USA). Data were tested for normal distribution (Shapiro-Wilk test) and 
subsequently analysed using repeated-measures ANOVA on two factors (treatment x time). 
Mauchly’s test was consulted and Greenhouse -  Geisser correction factor applied if 
sphericity was violated. Bonferroni adjustment was also performed and dependent t-tests 
carried out where necessary. Data are represented as mean ± SEM. Significance was set at P 
<0.05.
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4.0 RESULTS
4.1 Laboratory Conditions
The ambient air temperature in the laboratory was recorded and found to be comparable 
between trials, (DEX; 20.9 ± 0.2 vs. ISO; 21.1 ± 0.4 °C, P = 0.66) as was barometric pressure 
which was also recorded and found to be similar (DEX; 1019 ± 7 vs. 1027 ± 5 mbar, P = 
0.44).
4.2 Pre-Laboratory Dietary Intake
Dietary records for the previous 24 hours were analysed and participants (n = 6 ) consumed 
similar amounts o f energy intake (DEX; 5684 ±951 vs. ISO; 5252 ± 682 kJ, P = 0.61) with 
comparable amounts of CHO ingested (DEX; 191 ± 30.7 vs. ISO; 165.8 ± 27.5 g, P = 0.34).
67
4.3 G ly c a e m ic  a n d  M e ta b o l ic  R e sp o n se s
4.3.1 Blood Glucose
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Figure 4.1. Blood glucose responses following ingestion o f CHO, during sub maximal exercise, during 
the performance protocol and subsequent recovery period (A) illustrates absolute blood glucose 
responses and (B) illustrates relative blood glucose responses compared to resting sample, (o) hollow 
markers demonstrate significant changes from resting sample (P < 0.05). (*) denotes significant 
changes between conditions (P < 0.05). The first shaded area is representative o f the submaximal 
exercise and the second shaded area representative o f the high intensity performance running.
Resting blood glucose values were sim ilar betw een conditions (DEX; 9.1 ± 0.9 vs. ISO; 9.8 ±
1.3 m m ol'L '1, P = 0.64). There were no conditional differences in the absolute data, however 
pre-exercise relative blood glucose responses in the 2 hour resting period were lower in ISO 
(P = 0.001). Relative resting peak BG was 46%  lower after ingestion o f  ISO com pared to 
DEX (ISO; +5.6 ±  0.4 vs. DEX; +10.3 ± 0.7 m m ol'L '1, P < 0.001), and the tim e to reach this 
peak value took longer in ISO (86 ± 8 min) com pared to DEX (64 ± 4 m in) (P < 0.001).
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BG fell throughout the submaximal exercise and these reductions were similar between trials 
(DEX; -1.0 ± 0.5 vs. ISO; -1.9 ± 0.5 m m olL '1, P = 0.21), whereas after the performance bout 
BG levels had increased, again these changes were similar between conditions (DEX; 0.7 ± 
0.3 vs. ISO; 0.7 ± 0.4 mmol L 1, P = 0.98).
The lower glycaemic response after ingestion of ISO in the resting period for the first 90 
minutes is reflected in the IAUC (Equation D) data (Table 4.1). This response also results in 
the Total IAUC being significantly lower in ISO and also lower values for both of the 
exercise protocols.
Table 4.1 Incremental area under curve (IAUC) values throughout laboratory experimental period. 
(*) denotes significant higher values between conditions (P < 0.05).
DEX ISO P - value
Rest IAUC 847.6 ±72.4* 483.9 ±40.5 0.001
(mmol min L'1)
Submaximal IAUC 99.3 ±23.2 64.3 ± 12.3 0.251
(mmol minL'1)
Performance IAUC 64.7 ± 17.4 44.3 ± 11.2 0.342
(mmol minL'1)
Total IAUC 1057.9 ± 119.8* 624.2 ±67.1 0.009
(mmol minL'1)
One individual experienced an episode o f hypoglycaemia (BG <3.5 mmol L '1) in each of the 
two trials and was supplemented with CHO. In DEX, an extra 30 g of DEX was administered 
prior to the submaximal exercise and in ISO, 30 g of DEX was provided after completion of 
the performance exercise bout. Both CHO were equally effective in preventing 
hypoglycaemia during submaximal and maximal exercise.
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4.3.2 B lo o d  L a c ta te  a n d  p H
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Figure 4.2. Blood lactate (A) and blood pH  (B) responses following ingestion o f  CHO, during 
submaximal exercise, during the performance protocol and subsequent recovery period, (o) hollow 
markers demonstrate significant changes from resting sample (P < 0.05). (*) denotes significant 
changes between conditions (P < 0.05). The first shaded area is representative o f the submaximal 
exercise and the second shaded area representative o f the high intensity performance running.
Blood lactate values were significantly elevated throughout the pre-exercise resting period in 
ISO when com pared to DEX (P = 0.009). This finding is reflected in the peak resting values 
where peak values are higher in ISO when com pared to DEX (ISO; 2.2 ± 0.3 vs. DEX; 1.3 ± 
0.1 mmol I / 1, P = 0.10). Once exercise had begun there were no conditional differences 
between lactate concentrations (P = 0.85) and the onset o f  blood lactate accum ulation 
(OBLA; 4 m m ol'L '1) was reached by participants either in the final two increm ents or not at 
all during the subm axim al exercise in both treatm ents. Blood lactate concentrations increased 
with exercise intensity with peak lactate values occurring after com pletion o f  the perform ance 
bout, these values were sim ilar betw een conditions (DEX; 13.2 ± 0.7 vs. ISO; 12.6 ± 0.6 
m m ol'L '1, P = 0.53).
Pre Post Rec 
1 5
70
There was no conditional effect present in blood pH betw een trials (P = 0.99). Low est blood 
pH values occurred after the perform ance bout and were sim ilar betw een trials (DEX; 7.25 ± 
0.01 vs. ISO; 7.24 ± 0.01, P = 0.60).
4.3.3 Blood Electrolytes
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Figure 4.3. Blood electrolyte responses following ingestion o f CHO, during submaximal exercise, 
during the performance protocol and subsequent recovery period. (A) illustrates changes in blood 
Ca (B) illustrates changes in blood K  and (C) illustrates changes in blood Na levels. The first 
shaded area is representative o f the submaximal exercise and the second shaded area representative 
o f the high intensity performance running.
No conditional differences were present betw een any o f  the electrolyte concentrations (Ca ; 
P = 0.94, K+; P = 0.84, N a+; P -  0.89).
Concentrations o f  K and Na slow ly increased with an increase in exercise intensity during 
the subm axim al exercise, this relationship was not present in levels o f  Ca . All electrolyte
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concentrations increased after com pletion o f  the perform ance test. Peak levels o f  electrolytes 
were also sim ilar between conditions, (C a++, DEX; 1.17 ± 0.01 vs. ISO; 1.17 ± 0.01, P = 0.94, 
K +, DEX 5.6 ± 0.2 vs. ISO 5.4 ± 0.03, P = 0.54 , N a \  DEX; 142 ±  1 vs. ISO 142 ±  1 
m m ol'L '1, P = 1.00).
4.3.4 Blood Gases
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Figure 4.4. Blood gas responses following ingestion o f CHO, during submaximal exercise, during the 
performance protocol and subsequent recovery period. (A) illustrates changes in bloodpO 2 and (B) 
illustrates changes in blood pCOi. (o) hollow markers demonstrate significant changes from resting 
sample (P < 0.05). The first shaded area is representative o f the submaximal exercise and the second 
shaded area representative o f the high intensity performance running.
There were no conditional differences in either o f  the blood gas concentrations in each o f  the 
trials ( p 0 2; P = 0.44, p C 0 2; P = 0.87).
Levels o f blood p 0 2 were consistent during the rest period and for the first exercise intensity, 
following the first exercise intensity levels o f  blood p 0 2 increased during the subm axim al 
exercise and continued to rise before com m encem ent o f  the perform ance test. Levels o f  blood 
p ()2 then fell in both trials at a sim ilar rate (DEX; -7 ±  2 vs. ISO; -4 ± 2 m m H g, P = 0.32) 
after com pletion o f  the perform ance test. There were no conditional differences in peak levels 
o f  blood p 0 2 (DEX; 89 ± 2 vs. ISO; 89 ± 1 m m H g, P = 0.95).
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Blood p C 0 2 levels were constant during the rest period and after a slight increase following 
the first exercise intensity, the levels fell throughout the subm axim al exercise and continued 
to fall until cessation o f  the perform ance test. There were no conditional differences in 
m inim um  levels o f  blood p C 0 2 (DEX; 32 ± 1 vs. ISO; 33 ±  1 m m H g, P = 0.46).
4.3.5 Blood Haematocrit
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Figure 4.5. Changes in blood haematocrit levels following ingestion o f CHO, during submaximal 
exercise, during the performance protocol and subsequent recovery period, (o) hollow markers 
demonstrate significant changes from resting sample (P < 0.05). The first shaded area is 
representative o f the submaximal exercise and the second shaded area representative o f the high 
intensity performance running.
No conditional differences betw een CHO were present in levels o f  blood haem atocrit (P = 
0.59). M inim um  levels o f  blood haem atocrit occurred 60 m inutes after ingestion o f  CHO. 
m inim um  levels were sim ilar betw een trials (DEX; 44 ± 1 vs. ISO; 44 ± 1%, P = 0.93).
Throughout the subm axim al exercise DEX haem atocrit levels fluctuated whilst ISO levels 
rem ained fairly constant. Haem atocrit levels rose after com pletion o f  the perform ance test to 
peak values, the rise observed (DEX; 2 ±  1 vs. ISO; 2 ± 1%, P = 0.60) and peak levels (DEX; 
50 ± 1 vs. ISO; 50 ± 1%, P = 1.00) were sim ilar betw een conditions.
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4.4 Submaximal Exercise
4.4.1 Cardiorespiratory Responses
Table 4.2. Cardiorespiratory responses to exercise in each o f the trials. (#) denotes variable 
significantly higher than rest (P < 0.05).
Rest 31% 41% 53% 69% 80%
vE DEX 7.75 ± 19.22 ± 26.58 ± 37.09 ± 50.87 ± 62.54 ±
(Lm in1)
0.54 1.20* 2.21* 2.97* 4.07* 3.64*
ISO 9.83 ± 19.25 ± 25.00 ± 36.32 ± 51.11 ± 62.00 ±
0.79 0.89* 1.13* 2.37* 3.17* 3.52*
Vo2 DEX 0.28 ± 0.84 ± 1.11 ± 1.43 ± 1.90 ± 2.24 ±
(L min'1) 0.01 0.05* 0.05* 0.10* 0.14* 0.10*
ISO 0.31 ± 0.84 ± 1.08 ± 1.43 ± 1.89 ± 2.11 ±
0.02 0.04* 0.06* 0.09* 0.15* 0.11*
Vco2 DEX 0.24 ± 0.72 ± 1.04 ± 1.48 ± 2.00 ± 2.47 ±
(L min'1) 0.02 0.06* 0.08* 0.14* 0.18* 0.11*
ISO 0.29 ± 0.72 ± 0.99 ± 1.47 ± 2.02 ± 2.36 ±
0.02 0.05* 0.06* 0.12* 0.16* 0.11*
RER DEX 0.87 ± 0.86 ± 0.93 ± 1.02 ± 1.05 ± 1.11 ±
0.02 0.03 0.04 0.04* 0.04* 0.04*
ISO 0.92 ± 0.86 ± 0.92 ± 1.02 ± 1.07 ± 1.12 ±
0.03 0.03 0.03 0.03* 0.03* 0.02*
Heart Rate DEX 73 ± 5 102 ±6* 114 ±5* 134 ±5* 150 ±5* 168 ±7*
(beats min'1) ISO 79 ± 5 101 ±5* 116 ± 5* 132 ±6* 150 ±5* 164 ±7*
Manipulation of pre-exercise carbohydrate did not influence cardiorespiratory responses 
between trials as there was no conditional effect present in any of the variables (P > 0.05). 
Apart from RER responses all other variables increased on the commencement of the first 
exercise intensity and continued to increase after each increment. RER responses increased 
from the resting value in the 41% intensity in DEX and 53% intensity in ISO.
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At rest there is strong suggestion o f  a ventilatory cost and carbon dioxide output after 
ingestion o f  ISO and this factor is represented in the Ve (P = 0.051) and V C O 2 (P = 0.155) 
values.
4.4.2 Substrate Utilisation and Energy Expenditure
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Figure 4.6. Rates o f substrate utilisation and energy expenditure at rest and throughout submaximal 
exercise (A) illustrates changes in carbohydrate (CHO) oxidation and (B) illustrates changes in fa t 
oxidation (C) illustrates changes in energy expenditure (#) denotes oxidation rate significantly 
greater than rest (P < 0.05).
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Resting rates o f substrate utilisation (Equations A and B) were similar between conditions 
(DEX CHO; 0.19 ± 0.04, ISO CHO; 0.27 ± 0.04 g m in'1, P = 0.16., DEX Fat; 0.06 ± 0.01 vs. 
ISO Fat; 0.04 ± 0.01 g min , P = 0.34). During exercise, CHO combustion rates (Equation A) 
increase as exercise intensity increases in both conditions, whilst rates of fat combustion 
(Equation B) follow an inverse relationship and decrease as exercise intensity increases. CHO 
combustion was significantly higher in both conditions from the 53% exercise intensity 
onwards and additionally from 41% onwards in ISO. Fat oxidation was significantly higher 
than rest at the 31% stage in ISO but not in DEX.
There were no significant differences in combustion rates between conditions throughout the 
incremental intensities (CHO; P = 0.77, FAT; P = 0.46). No differences in exercising peak 
rates of CHO (DEX; 3.79 ± 0.32 vs. ISO; 3.67 ± 0.17 g m in'1, P = 0.75) or fat (DEX; 0.22 ± 
0.04 vs. ISO; 0.20 ± 0.04 g min , P = 0.73) oxidation between conditions were present either.
An increase in exercise intensity was accompanied with a rise in energy expenditure (EE), EE 
was comparable between treatments (P < 0.05) with peak levels in the final increment (DEX;
60.01 ± 4.56 vs. ISO; 57.38 ± 2.58 kJ min *).
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4.4.3 S u b s t r a t e  C o n t r ib u t io n s  to  E n e m y  E x p e n d i t u r e
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Figure 4.7. Fuel use contributions to energy expenditure at rest and throughout submaximal exercise 
(A) illustrates DEX contributions to EE (B) illustrates ISO contributions to EE (#) denotes oxidation 
contributions significantly different than rest (P < 0.05), (a) denotes oxidation contributions 
significantly different to first exercise intensity ( P < 0.05).
Resting carbohydrate contributions were sim ilar between conditions (DEX; 55.3 ± 8.3, vs.
ISO 70.9 ± 9.1% , P = 0.23) and there were no conditional differences in the subm axim al 
exercise (P = 0.46).
As exercise intensity increased the reliance o f  CEIO as the prim ary contributor to energy 
expenditure also increased. In the latter three increm ental stages the EE contribution o f  CHO 
was higher than the first exercise stage in both conditions and also higher than rest 
contributions in DEX. CH O contributions to EE were not different at any exercise intensity in 
the ISO trial. These changes in contributions were also m irrored in the rates o f  substrate 
utilisation (Figure 4.6).
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4.5 Performance Responses
4.5.1 Performance Variables
Table 4.3. Characteristics of performance trial for each condition, categorised into 2.5 minute 
quartiles. (c) denotes significantly longer than third exercising quartile.
Variable Quartile DEX ISO
Stride Length (m) 2.5 min 0.70 ±0.06 0.69 ± 0.05
5.0 min 0.72 ± 0.06 0.71 ±0.04
7.5 min 0.69 ± 0.06 0.71 ±0.04
10 min 0.75 ± 0.04 0.78 ± 0.04c
Mean 0.72 ± 0.05 0.72 ± 0.04
Average Speed (km h'1) 2.5 min 6.93 ± 0.63 6.48 ±0.58
5.0 min 6.72 ±0.59 6.65 ±0.57
7.5 min 6.69 ±0.58 6.82 ±0.50
10 min 7.23 ± 0.49 7.47 ±0.50
Mean 6.89 ±0.55 6.86 ±0.51
Number of Steps 2.5 min 409 ± 9 388 ± 17
5.0 min 389 ± 12 387 ±15
7.5 min 401 ± 10 400 ± 10
10 min 401 ± 10 400 ± 10
Total 1600 ± 3 6 1576 ± 39
Distance (km) 2.5 min 0.29 ± 0.03 0.27 ± 0.02
5.0 min 0.28 ± 0.02 0.28 ± 0.02
7.5 min 0.28 ± 0.02 0.28 ±0.02
10 min 0.30 ±0.02 0.31 ±0.02
Total 1.15 ±0.09 1.14 ± 0.09
RPE 18.1 ±0.5 18.0 ± 0 .7
There were no conditional differences in any of the variables at any o f the quartiles during the 
performance trial (P > 0.05). In the final exercising quartile, participants covered the most 
difference and maintained the fastest speed in each trial and although number o f steps did not 
increase, stride length did to compensate for the extra distance covered. The extra distance 
covered in the final quartile of the tests is also reflective on the cardiorespiratory variables 
(Table 4.4).
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4.5.2 Cardiorespiratory Responses
Table 4.4 Cardiorespiratory responses to the performance trial in each of the conditions categorised 
in 2.5 minute quartiles (a) denotes variable higher than first exercise quartile (P < 0.05), (b) denotes 
variable higher than second exercise quartile (P < 0.05), (c) denotes variable higher than third 
exercise quartile (P < 0.05).
Variable 2.5 Min 5 Min 7.5 Min 10 Min Mean
vE DEX 61.47 ± 84.04 ± 86.80 ± 94.43 ± 81.69 ±
(L m in1)
5.16 8.15a 7.99a 7.43a,b,c 6.99
ISO 56.07 ± 76.43 ± 84.39 ± 92.92 ± 77.45 ±
6.14 7.25a 7.19a,b 7.62a,b,c 6.84
Vo2 DEX 1.99 ± 0.18 2.40 ± 0.22a 2.41 ± 0 .22a 2.45 ± 0.19a 2.31 ± 0 .20
(L min'1)
ISO 1.88 ±0.20 2.32 ± 0.23a 2.43 ± 0.22a 2.44 ± 0.20a 2.27 ±0.21
Vco2 DEX 2.27 ± 0.24 3.10 ± 0.32a 3.05 ± 0 .3 l a 3.18 ± 0.27a 2.90 ± 0.28
(L min'1)
ISO 2.07 ±0.27 2.88 ± 0.33a 3.05 ± 0.32a 3.17 ± 0.28a 2.79 ± 0.29
Exercise DEX 73 ± 5 88 ± 6a 88 ± 6a 90 ± 5a 85 ± 5
Intensity ISO 69 ± 6 85 ± 6a 89 ± 6a 90 ± 5a 83 ± 6
(%V02 peak)
Heart Rate DEX 163 ± 6 178 ± 6 a 182 ± 5 ^ 186 ± 4 a 177 ± 5
(beats min'1) ISO 160 ± 5 177 ± 5 a 182 ± 5a,b 187 ± 4a,b,c 176 ± 5
No conditional differences through CHO manipulation were present between 
cardiorespiratory responses in the performance test (P > 0.05). Participants were exercising at 
a higher intensity for the last three exercising quarters in both conditions when compared to 
the first exercise quartile (P < 0.05). The increased exercise intensity is reflected in the other 
variables, a relationship similar to that observed in the submaximal exercise protocol data 
(Table 4.2).
Minute ventilation was higher in the final exercising quartile of both DEX and ISO when 
compared to the three previous exercising quartiles, furthermore in ISO the heart rate was 
also higher than all three previous exercise quartiles (P < 0.05).
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4.5.3 S u b s t r a t e  U ti l isa t io n  a n d  E n e r g y  E x p e n d i t u r e
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Figure 4.8 Fuel use and energy expenditure in the performance test. (A) illustrates rates o f  
carbohydrate oxidation and (B) illustrates energy expenditure for each o f the high intensity quartiles
Substrate utilisation during the perform ance running was dependent fully on CH O  oxidation, 
rates which was com parable between treatm ents (P > 0.05). Peak CH O  rates were observed in 
the first exercising quartile in DEX and in the final exercising quartile in ISO and were 
com parable (DEX ; 5.95 ± 0.75 vs. ISO; 6.10 ± 0.64 g m in 1).
As fuel oxidation was fully dependent on CHO oxidation, the EE values followed the sam e 
relationship as the carbohydrate oxidation w ith peak values com parable betw een treatm ent at 
the first and last quartiles in DEX and ISO respectively (DEX ; 92.82 ± 11.63 vs. ISO; 95.12 
± 10.04 kJ m in '1).
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4.6 Stroop Colour Word Test (SCWT)
Table 4.5. SCWT responses and scores in both trials. (#) denotes significantly quicker time than rest 
(P < 0.05).
DEX ISO
Rest Pre -  Ex Post -  Ex Rest Pre -  Ex Post -  Ex
Congruent
Score
9.9 ±0.1 10±0 10± 0 10± 0 10 ± 0 10± 0
Congruent 1.233 ± 1.215 ± 1.115 ± 1.157 ± 1.155 ± 1.067 ±
Time (s) .063 .084 .076 .099 .065 .064
Incongruent
Score
10±0 10± 0 10± 0 9.7 ±0.3 10 ± 0 10± 0
Incongruent 1.387 ± 1.374 ± 1.222 ± 1.392 ± 1.257 ± 1.209 ±
Time (s) .070 .089 .075 .076 .099# .090#
Stroop 0.154 ± 0.159 ± 0.107 ± 0.235 ± 0.102 ± 0.142 ±
Effect (s) .038 .065 .040 .077 .077 .041
There were no conditional differences in scores or times for either the congruent (word and 
colour identical; score; P = 0.36, time; P = 0.19) or incongruent (word and colour different; 
score; P = 0.36, time; P = 0.39) elements of the SCWT. No conditional differences were 
present either in regards to the Stroop effect (P = 0.59).
In both trials, congruent times were quicker than incongruent times, and subsequent 
incongruent times after consumption of ISO were quicker than the resting value (Rest vs. Pre- 
Ex; P = 0.01, Rest vs. Post-Ex; P < 0.01).
Scores for both congruent and incongruent elements were similar at all sample points and 
also between conditions.
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4.7 Gut Fullness and Hunger Ratings
Table 4.6. Perceived ratings of gut fullness and hunger in both trials. (#) denotes perceived rating 
significantly different to rest (P < 0.05).
DEX ISO
Rest Pre -  Ex Post -  Ex Rest Pre -  Ex Post -  Ex
Perceived Gut 3.6 ±0.3 4.0 ± 0.5 4.7 ± 0.4* 2.4 ± 0.5 3.9 ±0.3 4.1 ±0.6
Fullness Rating
Perceived Hunger 6.7 ± 0.3 6.3 ± 0.5 5.1 ±0.7 6.9 ± 0.5 5.7 ± 0.2 6.1 ±0.5
Rating
Perceived feelings of gut fullness increased in both trials after consumption o f CHO, fullness 
was reported to be greatest after completion of exercise, although there were no conditional 
differences between trials (P = 0.11).
Perceived hunger ratings were also highest at rest before CHO ingestion and ratings were 
lower in both conditions at the pre and post exercises stages. In DEX there is a suggestion of 
appetite suppression after completion of exercise where a drop in hunger feeling is observed 
as opposed to an increase in ISO. There were no conditional differences between 
carbohydrates (P = 0.54).
4.8 Post Laboratory Results
4.8.1 Blood Glucose
Table 4.7 Self-reported BG values 3 and 6 hours after leaving the laboratory (#) denotes value 
significantly different to Oh.
DEX ISO
0 h (n = 6) 3 h (n = 6) 6h (n  = 5) 0 (n = 6) 3 (n = 6) 6 (n = 5)
BG 13.8 ±2.0 12.8 ±2.7 9.0 ± 0.9ff 12.0 ±1.8 10.4 ±1.3 9.2 ± 1.6
(mmol.L'1)
Relative BG 4.7 ±1.9 3.7 ±3.3 -0 .6 ± 1 .8 # 2.9 ±1.3 1.4 ±2.0  - 0.4 ± 2.0
(mmol.L'1)
BG levels fell over the 6  hour self-reported period in both trials, with no conditional effect 
between treatments in either absolute or relative BG values (P > 0.05). 6  hour reported BG
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values were significantly lower in DEX when compared to BG levels when leaving the 
laboratory. In both conditions 6  hour values were lower than baseline values taken at rest.
4.8.2 Insulin Doses and Dietary Intake
Participants (n = 5) self-reported their dietary intakes after leaving the laboratory for the 
remainder of the day. Participants tended to consume less energy intake after completion of 
the ISO trials (DEX; 5258 ± 616 vs. ISO; 4008 ± 503 kJ, P = 0.17) with less CHO intake also 
reported (DEX; 152.0 ± 18.8 vs. ISO; 113 ±20.0  g ,P  = 0.10).
There were no differences in meal time insulin doses between trials (DEX; 18.0 ± 3.3 vs. 
ISO; 17.4 ± 2.3 U, P = 0.89). Two participants also reported that after the DEX trial they 
administered corrective doses o f 4 and 2U respectively of their rapid acting insulin in an 
attempt to lower their elevated levels of BG. There were no reports of corrective doses 
administered post ISO trials.
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5.0 DISCUSSION
5.1 Aim and Main Findings
This study investigated the metabolic, substrate and exercise performance responses in 
T1DM individuals after ingesting 0.6 gkg "1 BM (10% solution) of either DEX (high GI) or 
ISO (low GI) in combination with a 50% reduced dose of rapid-acting insulin 2 hours prior to 
exercise. Levels o f glycaemia were found to be improved after ingestion of ISO without any 
performance differences on subsequent high intensity running.
5.2 Rest
Pre-exercise relative blood glucose concentrations were higher in DEX (GI = 100, Chapter 
3.3.2.1) compared to ISO (GI = 53, Chapter 3.3.2.1), these observations would have a result 
o f the different GI values between CHO and the 2 hour IAUC responses associated with 
calculating GI (Brouns et al., 2005; Jenkins et al., 1981). The lower glycaemic responses and 
associated relative peaks (ISO; +5.6 ± 0.4 vs. DEX; +10.3 ± 0.7 mmolL"1, P < 0.001) 
witnessed are consistent with previous investigations (West et al., 2011b; Chapter 3.3.2.1). 
The longer time to reach peak resting blood glucose concentration in ISO is also reflective of 
the different GI values. The process of hydrolysis and subsequent absorption of derived 
fructose and glucose in ISO results in a somewhat slower, lesser peak than that observed in 
DEX (Lina et al., 2002). In order to cross the brush border membrane fructose needs to be 
aided by the transport protein, GLUT 5, moving down a concentration gradient before uptake 
into mucosal cells can take place via the process o f facilitated diffusion (Frayn, 1996). The 
derived glucose in ISO and DEX can readily cross the brush border membrane and pass into 
the enterocytes by active transport mediated via the sodium glucose co-transporter 1 (SGLT1) 
and increase BG levels quickly (Frayn, 1996; West et al., 201 lb). These findings resulted that 
null hypothesis i could be rejected for glycaemic responses at rest.
Throughout the 2 hour resting period blood lactate was higher after ingestion o f ISO at all 
sample time points with this observation translated in the higher resting peak values (DEX;
1.3 ± 0.1 vs. ISO; 2.2 ± 0.3 mmol L '1, P = 0.016) of which similarities have been witnessed in 
previous investigations (West et al., 2011b: Chapter 3.3.2.1). Conditional differences in 
regards to lactate meant that null hypothesis i was rejected for the rest period. The time to
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reach these peak lactate values were similar between conditions (DEX; 94 ± 8  vs. ISO; 8 6  ± 8  
min, P = 0.454). Carbohydrate feeding alone promotes glycolysis and lactate production even 
at rest, glucose entering the resting muscle is phosphorylated to glucose-6 -phosphate and this 
subsequently leads to glycolysis (Houston, 1995). The further elevated levels o f blood lactate 
in ISO can be explained by the metabolism of this disaccharide into fructose and glucose. The 
resultant fructose bypasses the phosphofructokinase regulatory point in glycolysis and leads 
to an increased flux through the glycolytic pathway which in turn leads to a build-up and 
subsequent release of lactate (Kaye et al., 1958; Sahebjami & Scalettar 1971).
In addition to the increased lactate levels in ISO, are higher rates o f minute ventilation (V e)
and carbon dioxide output (VCO2). The pyruvate resulting from glycolysis has two fates, one 
of which is the reduction to lactate and appearance in the bloodstream via the enzyme lactate 
dehydrogenase (LDH) and the second is the entrance into the mitochondria. Once in the 
mitochondria, pyruvate is converted into acetyl CoA using pyruvate dehydrogenase for 
subsequent oxidation to water and carbon dioxide (Houston, 1995). This second fate of
pyruvate may explain the recorded higher Ve and VCO2 (Table 4.2, Figure 5.1) witnessed in 
this study.
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Figure 5.1 Schematic representations o f  blood glucose and lactate responses following 
ingestion o f  either DEX (5. l.A) or ISO (5. l.B), compiled using data from  Frayn (1996); 
Houston (1995); Kaye et al., (1958); Lina et al., (2002); Sahebjami & Scalettar (1971)
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5.3 Submaximal Exercise Protocol
During discontinuous incremental submaximal exercise, blood glucose concentrations 
declined at a comparable rate from the start o f the exercise until the last increment (DEX;
- 1.0 ± 0.5 vs. ISO; - 1.9 ± 0.5 mmol'L"1, P = 0.21). Although there were no differences 
between the total level of decline throughout the submaximal exercise the rate of fall was 
different between treatments. In DEX blood glucose dropped at a steady rate of 0.1 mmol L"1 
regardless of exercise intensity following each increment after an initial 0.6 mmol L ' 1 decline 
at the onset o f exercise, however, in ISO blood glucose fell 0.5 mmol L ' 1 at the beginning of 
exercise and then dropped a further 0.2 -  0.5 mmol L' 1 per exercise increment with the rate of 
fall slowing slightly as exercise intensity increased. As blood glucose concentrations were 
comparable during the submaximal protocol the criteria for null hypothesis i was fulfilled.
The blood glucose decline observed in this time period could be attributable to the levels of 
circulating insulin in the bloodstream. As insulin is exogenously administered levels do not 
decrease at the start o f exercise as they do in healthy individuals which in combination with 
an insufficient glucagon response results in no change in the ratio of insulin to glucagon. An 
unchanged ratio means that there is an increased risk that the fuel requirement required for 
exercise will not be matched by hepatic glucose production (Lumb & Gallen, 2009). In 
addition, the usual portal to systemic insulin ratio is reversed which results in a higher insulin 
concentration in the periphery (Lumb & Gallen, 2009), the increased insulin concentration 
promotes peripheral muscle glucose uptake further reducing levels of blood glucose 
(Goodyear & Kahn, 1998). Furthermore, the observed reductions in blood glucose could be 
related to the time length of the submaximal exercise (26 minutes) as for the initial 2 0  -  60 
minutes of exercise, individuals with T1DM are more susceptible to exercise induced 
hypoglycaemia (Riddell et al., 1999).
By the end of the first 4 minutes of exercise no differences were longer evident between 
conditions in blood lactate concentrations (DEX; 1.3 ± 0.1 vs. ISO; 1.4 ± 0.2 mmol L’1, P = 
0.28). As the first increment of exercise was of low intensity similar to the intensity used
(29% vs. 31% VO2 peak) during active recovery it is possible that the removal of lactate in 
ISO occurred within the skeletal muscles (McGrail, Bonen & Belcastro, 1978). Additional 
increases of exercise intensity as the incremental protocol progressed also resulted in an
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increase o f blood lactate concentrations with these levels again comparable between 
treatments (P > 0.05), therefore similar anaerobic threshold running intensities were observed 
between conditions in spite of the higher lactate levels at rest in ISO. An increase in exercise
intensity beyond 50 -  60% VO2 m ax  promotes an increase in rate o f glycolysis and the 
subsequent increase in pyruvate production. The derived pyruvate is produced at a quicker 
rate than the rate of glycolysis such that a significant amount is reduced to lactate (Houston,
1995). The levels o f blood pH are reportedly linearly related to blood lactate and pyruvate 
concentrations (Saltin, 1975), therefore as blood lactate rises as the exercise intensity 
increases, an associated decrease in blood pH is observed (Figure 4.2). Therefore, null 
hypothesis i was fulfilled in regards to blood lactate and pH concentrations.
Hyperglycaemic levels at the onset (DEX; 15.0 ± 1 . 9  vs. ISO; 14.6 ± 1 . 5  m m olL '1) and 
throughout the submaximal exercise protocol (DEX; 14.5 -  14.0 vs. ISO; 14.1 -  12.7 
mmol L '1) may have suppressed lipid oxidation (Jenni et al., 2008; West et al., 2010; West et 
al., 2 0 1 1 b) and therefore the potential for any carbohydrate sparing witnessed in previous 
studies (Febbraio et al., 2000; Wee et al., 2005) to be blunted. The short duration of intervals 
and/or only a relatively small decline in blood glucose ~ 1.0 mm olL ' 1 may also have 
attributed to no differences observed in regards to lesser suppression of lipid oxidation as 
observed in previous research comparing these two carbohydrates (West et al., 201 lb).
However, the suppression of lipids could simply be a result of pre-exercise carbohydrate 
provisions and oxidation shifting to predominately carbohydrate after the ‘crossover’ point at 
a certain exercise intensity (Brooks & Mercier, 1994). Exercise is typically fuelled by four 
main components: muscle glycogen, muscle triglycerides, plasma free fatty acids and plasma 
glucose, the utilisation and selection o f these choices vary and are determined in relation to 
exercise intensity performed (Romijn et al., 1993). Exercising at different intensities is 
reflective in the energy expenditure, i.e. the higher the intensity o f exercise performed the 
greater the energy expenditure and vice versa. As exercise intensity increases lipids cannot be 
oxidised quickly enough to supply the required fuel and therefore carbohydrates become the 
dominant substrate with glycogen stores in the liver and muscles providing this required 
energy (Coyle, 1995, Figure 4.7). This also offers an explanation as to the higher rates of 
carbohydrate oxidation as the increments progressed and the energy intensity and
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expenditures both increased. Comparisons in substrate utilisation in both treatments resulted 
in the criteria for null hypothesis ii to be fulfilled.
Pre-exercise provision of carbohydrate could also offer explanation as to the peak oxidation 
rates in this study were lower than the documented ‘fatmax’ values in which the participants 
exercised in the fasted state (Achten et al., 2002). Individual peak oxidation rates occurred in
the initial increments at the low exercise intensities 31 or 41% VO2 peak independent of 
treatment and fat utilisation was comparable with resting oxidation values in the latter stages 
of the incremental protocol. Lipid oxidation has been shown to be directly regulated by the 
availability of carbohydrate (Coyle et al., 1997; Turcotte, Swenberger & Yee, 2002), high 
carbohydrate availability promotes long chain fatty acid uptake and decreases oxidation in the 
muscle most likely due to malonyl-CoA inhibition in the mitochondria (Sidossis, Gastaldelli, 
Klein & Wolfe, 1997; Turcotte et al., 2002). Carbohydrate (glucose) can also be observed as 
the dominant fuel at lower intensities where an insulin response to a recent meal or continued 
carbohydrate feeding inhibits lipolysis (Marliss & Vranic, 2002).
Electrolyte responses were comparable between treatments during the submaximal exercise 
protocol (P > 0.05) and therefore fulfilled the criteria for null hypothesis i to be accepted. The 
initial rise and then consistent decline in calcium ions is explained due to the transport and 
increased uptake for subsequent regulation of contraction of the working muscles through the 
troponin-tropomyosin (Ebashi, 1972) and as the intensity of exercise increases so does the 
demand on the working muscles and associated calcium ion uptake for contraction (Ebashi, 
1972). Potassium levels are intensity related and concentrations rise after every incremental 
stage of the submaximal protocol as exercise intensity increases and more potassium is 
released into the circulation from the working muscles (Vollestad et al., 1994). Sodium and 
potassium concentrations follow a similar relationship due to the regulation o f these ions at 
the Na++/K+ pump and interchange of ions against their respective concentration gradients 
(Medbo & Sejersted, 1990). This relationship is the major influence in regulating both 
sodium and potassium levels as via skeletal Na+-K+-ATPase cellular sodium is released in 
exchange for potassium uptake. The exchange is crucially important in protecting both 
excitability and contractility of the muscle membrane (Sejersted & Sjogaard, 2000).
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5.4 Performance Test
In contrast to the decline in blood glucose witnessed in both conditions during the 
submaximal exercise protocol, blood glucose increased after the completion of the 
performance test. The increases observed were comparable between treatments (DEX; + 0.7 
± 0.3 vs. ISO; + 0.7 ± 0.4 mmol L '1, P = 0.98) with the rise in blood glucose a resultant of the 
increased exercise intensity. Similar responses have been seen in previous research after a 
period of high intensity exercise with the reasoning attributed to a rise in hepatic glucose 
production that exceeds the rate of utilisation (Mitchell et al., 1998). Hepatic production of 
blood glucose is generally accepted to be regulated by the release of catecholamines 
(Howlett, Febbraio & Hargreaves, 1999; Kjaer, Kiens, Hargreaves & Richter, 1991; Mitchell 
et al., 1998), production is said to increase seven to eightfold in comparison to utilisation
which only increases three to fourfold at exercise intensities above 80% VO2 m ax  (Marliss & 
Vranic, 2002; Purdon et al., 1993). Glucose utilisation decreases quicker than glucose 
production at exhaustion and in non-diabetic individuals is accompanied by a substantial rise 
in insulin for 40 -  60 minutes to restore euglycaemia. T1DM individuals do not have this 
insulin response and this absence results in a sustained period of hyperglycaemia (Lumb & 
Gallen, 2009; Marliss & Vranic, 2002).
The increased intensity of exercise sustained during the performance test also led to an 
increase in the levels o f blood lactate, so much so that at the end of the exercise blood lactate 
concentrations were at their peak in both conditions (DEX; 13.2 ± 0.7 vs. ISO; 12.6 ± 0.6 
mmol L '1, P = 0.53). Given the further increase in exercise intensity than performed during 
the submaximal running there was an even greater dependence on anaerobic metabolism to 
continue to fuel the working muscles during this performance test. As discussed previously in 
both the rest period (Chapter 5.2) and the submaximal exercise protocol (Chapter 5.3), 
pyruvate is produced as a result of glycolysis and the fate of some of this pyruvate is the 
conversion into lactate (Houston, 1995, Figure 5.1). The greater appearance of lactate the 
bloodstream in both treatments also suggests that the exercising muscles are unable to oxidise 
the pyruvate generated by glycolysis via the tricarboxylic acid cycle as efficiently at higher 
intensities (Marliss & Vranic, 2002). Levels o f pH are reportedly linearly related to the blood 
lactate and pyruvate concentration values (Saltin et al., 1975), the decrease in pH after the
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performance test reflects the increase in acidity of the blood somewhat suggestive of a higher 
concentration in circulating H+ ions in the bloodstream.
The rates of carbohydrate combustion and energy expenditure were both higher in the final 
three quartiles of the performance test than during any of the increments in the submaximal 
protocol. The increases in rates of energy expenditure are reflective of the higher effort 
exerted by the participants in the performance test. As witnessed with the incremental stages 
in the submaximal protocol, in order to carry out the extra effort required the body needs to 
meet the energy demands of the working muscles. The increased energy expenditure also 
resulted in an increased rate o f carbohydrate oxidation, at exercise intensities above 80%
VO2 m ax  fuelling of working muscles is almost entirely dependent on glucose and glycogen 
with little or no dependence on lipid oxidation (Marliss & Vranic, 2002). One reason for this 
dependence is that the body cannot oxidise lipids at a quick enough rate to efficiently fuel the 
muscles (Coyle, 1995) and secondly with a higher level o f pyruvate generation from 
glycolysis, most o f the end product is lactate where only a small fraction of ATP is available 
(Marliss & Vranic, 2002). Fuelling of intense high intensity exercise is derived from 
intramuscular and liver glycogen stores as well as from circulating glucose (Coyle, 1995; 
Marliss & Vranic, 2002). With no differences between rates of carbohydrate oxidation or 
distance covered in total or in each 2.5-minute quartile observed it can be assumed that both 
treatments are equally effective at fuelling subsequent high intensity exercise. The greater
rate of exertion in the performance test is also mirrored in the respiratory variables (V e , VO2 , 
V C 02, RER and HR. Table 4.4).
Electrolyte changes during the high intensity performance running were comparable between 
treatments (P > 0.05). The running assessment resulted in a rapid loss of potassium from the 
exercising muscles which would have been released into the circulation (Vollestad et al., 
1994) with these circulating levels dropping during the rest period reflective o f the immediate 
uptake by the muscles regulated somewhat by the Na+ - K+ pump (Medbo et al., 1990). This 
regulation in combination with loss through sweat could offer an explanation as to the similar 
observation in the concentration pattern of sodium ions (Vrijens & Rehrer, 1999). However 
in contrast to recent literature (Harmer et al., 2006) levels of potassium declined without the 
administration of insulin at the 15 minute recovery sample point as opposed to remaining 
elevated. The pre-exercise hyperglycaemic blood glucose levels may have accounted for this
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observation in this study as the relationship was reportedly only present in late recovery when 
the individual was not mildly hyperglycaemic (Harmer et al., 2006). After completion o f the 
performance running, the 15 minute sodium levels were reduced which is consistent with the 
work o f Harmer and colleagues (2006). In regards to calcium, the drop in blood pH observed 
may inhibit the binding of ions to troponin lessening the contraction force and potentially 
contribute towards muscular fatigue (Frayn, 1996; Leppik et al., 2004). Inhibition of the 
binding of these calcium ions offers some explanation to the increased concentrations 
observed following the performance running.
No research has previously directly investigated the performance responses of T1DM 
individuals after manipulation of their pre-exercise carbohydrate. In this study there were no 
observed differences between distances covered in the ten minute time limit (Table 4.3), thus 
meaning the criteria for null hypothesis iii to be accepted was fulfilled. The short duration of 
the performance test may have accounted for the comparable distances covered in the 
treatments, no differences were found previously in a performance test of similar length in 
which power output was measured (Sparks et al., 1998) with improvements in performance in 
both time to exhaustion and time trial tests lasting between 98.7 -  108.8 minutes in non­
diabetic individuals. Differences in performance bouts of short duration has also been 
observed (DeMarco et al., 1999) however in this instance the participants were exercising
maximally (100% VO2 m ax)  to exhaustion as opposed to 83 -  85% VO2 peak in a time trial 
protocol in this study. It appears that low GI CHO supplementation is potentially more 
beneficial to performance in prolonged duration/distance events or for very short maximal 
intensity activities. However, the important finding in this research is that performance is not 
compromised by low GI CHO supplementation and lower blood excursions in exercising 
T1DM individuals. Therefore, T1DM individuals can improve their glycaemic control with 
the knowledge that their exercise performance would be maintained and the same as if they 
had consumed a high GI CHO prior to exercising.
5.5 Further observations, recovery, post laboratory period and clinical significance
In general, glycaemia as reflected in IAUC values (Table 4.1) was improved throughout the 
laboratory period after ingestion of ISO in comparison to DEX with the lesser excursions in
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the rest period accounting mainly for this finding. Post-performance recovery blood glucose 
levels in participants, however, were still high in both conditions (DEX; 14.7 ± 1.9 vs. ISO;
13.7 ± 2.2 m m olL '1) to levels of hyperglycaemia which is a possibility when T1DM 
individuals engage in exercise at high intensities such as those encountered during the 
performance test (Mitchell et al., 1988). BG concentrations remained elevated for the 6 hour 
post-laboratory period (Table 4.7) which could be detrimental to the individual’s health if  
continually or frequently experienced as hyperglycaemia has many associated risk factors 
(Peirce, 1999). A potential clinical treatment for improving these levels of glycaemia may be 
the administration of corrective doses of rapid-acting insulin and/or the adoption o f lesser 
reductions in pre-exercise rapid-acting dosage if  engaging in high intensity exercise. In 
regards to corrective insulin administration two individuals reported administrating corrective 
doses following DEX, thus further suggesting ISO better limited hyperglycaemia. Another 
important consideration is that both treatments were equally effective at preventing 
hypoglycaemia with only one individual experiencing symptoms of hypoglycaemia in each of 
the trials, similar observation were witnessed when comparing these two carbohydrates 
during and after continuous moderate intensity exercise (West et al., 201 lb).
The post laboratory blood glucose responses in this research could also conceivably be 
compared to those responses witnessed by Bussau and colleagues (2007) as the participants 
in the final moments of the ten minutes all (without direction) performed a ‘sprint finish’ in 
an attempt to maximise their distance covered.
A final small observation is in regards to hydration and the similar range of values observed 
between treatment in both the sodium which throughout the laboratory period were between 
the normal range of 135 -  146 m m olL '1 (Figure 4.3) and haematocrit (Figure 4.5) values 
demonstrate individuals were kept euhydrated and consistent with previous literature 
(Perrone et al., 2005).
The clinical significance of this study is based around the glycaemia findings as expressed in 
the blood glucose IAUC values. All o f the participants had a lower IAUC value after 
consumption of ISO, with the main finding indicative of the lower blood glucose excursions 
witnessed in the rest period. Glycaemic control is of great importance in T1DM and any 
nutritional interventions that can improve glycaemic responses are of clinical significance. 
ISO consumption has previously been shown to be as effective at preventing the incidence of
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hypoglycaemia as DEX (West et al., 2011b) and this research has now established that 
exercise performance is also not compromised after ISO consumption. Therefore, ISO could 
be recommended to those T1DM individuals who wish to improve their glycaemic responses 
during and after exercise without impacting upon their ability to perform exercise at a high 
intensity.
5.6 Cognitive function and gut fullness
Resting blood glucose values were 9.1 ± 0.9 and 9.8 ± 1 . 3  mmolL"1 in DEX and ISO 
respectively with pre-exercise (DEX; 15.0 ± 1.9, ISO; 14.6 ±1.5 m m olL '1) and post-exercise 
(DEX; 14.7 ± 1.9, ISO; 13.7 ± 2.2 m m olL '1) concentrations deemed hyperglycaemic. 
Cognitive function improved slightly in hyperglycaemia when compared to ‘euglycaemia’ 
more evidently in the incongruent ISO scores, more importantly cognitive abilities did not 
appear to be weakened by hyperglycaemia and function sustained as reported in previous 
literature (Draelos et al., 1995; Gschwend et al., 1995).
The sustained and slightly improved cognitive functioning may also be due to carbohydrate 
supplementation especially after ISO supplementation where low GI interventions have 
witnessed prolonged memory and accuracy answering (Benton et al., 2003; Ingwersen et al., 
2007) generally credited with the potentially lower insulin response with low GI foodstuff 
(Jenkins et al., 1987) and the link between insulin and cognitive function (Benton et al., 
2003). The observed decreased times on the Stroop test following exercise is likely due to 
increased activation of the central nervous system after strenuous exercise (Hogervorst et al.,
1996) and may suggest why no conditional differences were found.
Gut fullness and hunger were not different between treatments in the laboratory period at any 
of the time points, these findings are consistent with Stevenson et al., (2005) where no 
differences were observed after the breakfast meal. Another potential reason for no treatment 
differences, even though there are published findings in regards to satiety and weight 
management after low GI intervention could be the moderately small amounts of 
carbohydrate provided in each instance (DEX; 41.89 ± 1.15 vs. ISO; 41.82 ± 1.26 g). The 
reported gut fullness scores (Table 4.6) with no indication of any gastrointestinal discomfort 
with a similar drink concentration is in agreement with previous literature (Perrone et al., 
2005).
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Although there were no recorded perceived feelings of satiety, interestingly in the six hour 
self-reported dietary intake, there was a tendency for less energy intake (P = 0.17) and fewer 
carbohydrates (P = 0.10) to be consumed after ISO ingestion. These findings are of important 
consideration as they are similar to those of long term follow up interventions (Henry et al., 
2007) thus suggesting that weight management could be enhanced with low GI 
supplementation. Improvements in weight management can further benefit insulin sensitivity 
and glycaemic control as reflected in decreased HbAic scores (Kaukua, Pekkarinen & 
Rissanen, 2004).
Although these findings in regards to cognitive function and gut fullness and hunger ratings 
fulfilled both the null hypotheses iv or v, differences were present in other literature (Benton 
et al., 2003; Ingwersen et al., 2007; Warren, Henry et al., 2003) in either the assessment of 
cognitive functioning or perceived feelings o f gut fullness and hunger, the methods adopted 
could be questioned. The gut fullness and hunger scales were only values between 0 - 1 0 ,  and 
with a small sample o f participants and only a few scores on the scale could have contributed 
to no differences being located. Increasing the values on the scales from 0 - 2 0  would double 
the choices available to the participants and may locate the differences that have been 
previously documented (Warren, Henry et al., 2003). In regards to the cognitive functioning 
assessment, the SCWT assessment has been recognised to be an established method. 
However, in a sporting and exercise context, a more ecological method could have been 
incorporated into the testing protocol. For example, reaction times are a very simple 
measurement to record and by testing for reaction times instead of assessing a more thinking 
cognitive test, the findings could be more applicable in exercise and competition.
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6.0 CONCLUSIONS AND RECOMMENDATIONS
6.1 Conclusions
Limited research is available in regards to exercise performance and choices o f carbohydrate 
supplementation in T1DM.
After ingestion o f ISO compared to DEX there is demonstration of improved glycaemia with 
less blood glucose excursions evident during the 2 hour rest period and throughout the 
experimental period as demonstrated in IAUC values. Lactate levels were also elevated in 
ISO during the rest period and there was a concern that these levels could influence 
subsequent performance. However, once the individuals began to exercise, the levels of 
lactate were comparable between conditions and exercise performance was not compromised.
Supplementation of either ISO or DEX prior to exercise does not appear to influence 
substrate utilisation in subsequent submaximal exercise of progressive incremental 
intensities. This suppression may be influenced by a number o f reasons, these include 
beginning exercising in hyperglycaemia, the availability of carbohydrate and the potential 
that the cross-over point of substrate utilisation was shifted before the reported ‘fatmax’ 
exercise intensity (Achten et al., 2003). Exercising at intensities that predominantly utilise 
lipid oxidation could be potentially beneficial to T1DM individuals as lesser reliance on 
carbohydrate oxidation can influence later levels of glycaemia.
Therefore in conclusion, 2-hour pre-exercise supplementation of 0.6 g kg '1 BM of ISO in 
combination with a 50% reduced dose of rapid-acting insulin improves glycaemia pre-, 
during and post-exercise with no decline in running performance. ISO supplementation has 
now been documented to equally protect against incidences o f hypoglycaemia (West et al., 
2011b) and also limit the level of hyperglycaemia following high intensity running when 
compared to a high GI CHO. The improved glycaemia, sustained exercise performance and 
other documented benefits of incorporating low GI CHO in the daily diets of T1DM 
individuals (Brand-Miller et al., 2003; Gilbertson et al., 2001; Nansel et al., 2008) are all 
important observations in this study.
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6.2 Limitations and recommendations for future research
6.2.1 Limitations
This present study only intended to give a simplistic insight in the metabolic responses during 
exercise with more emphasis on the performance responses, repeating this study with the 
additional analysis of hormones (insulin, catecholamines etc.) could provide a more definitive 
answer to the glycaemic responses witnessed in the exercise protocols, especially in the post­
performance setting. The main limitations o f this study are listed below:
a) This study only had a small population cohort (n = 7), the recruitment o f further 
individuals may have highlighted some subtle differences that require more statistical power 
to be generated. On the recommendations of Rabasa -  Lhoret et al., (2001) and West et al.,
(2010) a cohort o f around 33 would generate 80% statistical power.
b) The reliance on participants to self-report post laboratory blood glucose concentrations and 
dietary intake was a limitation in this research as some participants either did not return or 
fully complete the recording sheets. For this reason the potential for findings (if any) in the 
post laboratory/exercise period could have been lessened.
c) As no differences were found between the gut fullness scores or the cognitive functioning 
assessments even though previous research had shown there to be differences when low GI 
foodstuff had been provided. This may be a limitation o f the methods adopted in assessing 
both perceived hunger and fullness rating and cognitive functioning.
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6.2.2 Recommendations
a) Adopting a longer observational period following the performance testing would allow for 
a range of post-exercise insulin strategies to be adopted. Administration of insulin units 
following high intensity exercise would mimic the response in non T1DM individuals 
however it would be of importance to investigate the optimum dose to administer.
b) In a recent review article, O’Reilly et al., (2010) suggested that glycaemic load (GL; GL = 
GI x amount o f carbohydrate available (g)) would be a much better predictor of glycaemic 
responses than CHO amount/percentage or GI alone. The article also commented that the 
effect of the GI and GL on exercise performance is an issue that should be investigated 
further in an attempt to develop more comprehensive guidelines on the topic that could be 
developed in the future. Both GI and GL have their practical origins in a more clinical setting. 
Few studies have investigated the importance of the glycaemic load in regulating blood 
glucose responses during subsequent exercise. An experiment conducted by Chen et al., 
(2008) investigated the impact of three meals with varying GLs and GIs on metabolic 
responses during and after exercise. No differences were found between the low GL meals 
(Low GI -  Low GL and High GI -  Low GL), although both had findings that were 
significantly different to that of the High GL meal. Thus suggesting that the GL has an 
important role is determining subsequent metabolic responses. With the suggestion that GL 
has importance in a clinical setting, supplementation of a high GI carbohydrate matched for 
GL with a low GI carbohydrate ingested pre-exercise in T1DM warrants investigation. 
Potentially findings especially in reference to the glycaemic responses before, during and 
after exercise would certainly be of some interest.
c) In T1DM glycogen utilisation during exercise is more important than plasma glucose 
oxidation. In regards to this it may be beneficial to investigate the optimum osmolality that 
promotes better gastric emptying and quicker liver and muscle glycogen storage.
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